1
|
Li Z, Xue L, Yang J, Wuttke S, He P, Lei C, Yang H, Zhou L, Cao J, Sinelshchikova A, Zheng G, Guo J, Lin J, Lei Q, Brinker CJ, Liu K, Zhu W. Synthetic Biohybrids of Red Blood Cells and Cascaded-Enzymes@ Metal-Organic Frameworks for Hyperuricemia Treatment. Adv Sci (Weinh) 2024; 11:e2305126. [PMID: 38054350 PMCID: PMC10837374 DOI: 10.1002/advs.202305126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/26/2023] [Revised: 10/19/2023] [Indexed: 12/07/2023]
Abstract
Hyperuricemia, caused by an imbalance between the rates of production and excretion of uric acid (UA), may greatly increase the mortality rates in patients with cardiovascular and cerebrovascular diseases. Herein, for fast-acting and long-lasting hyperuricemia treatment, armored red blood cell (RBC) biohybrids, integrated RBCs with proximal, cascaded-enzymes of urate oxidase (UOX) and catalase (CAT) encapsulated within ZIF-8 framework-based nanoparticles, have been fabricated based on a super-assembly approach. Each component is crucial for hyperuricemia treatment: 1) RBCs significantly increase the circulation time of nanoparticles; 2) ZIF-8 nanoparticles-based superstructure greatly enhances RBCs resistance against external stressors while preserving native RBC properties (such as oxygen carrying capability); 3) the ZIF-8 scaffold protects the encapsulated enzymes from enzymatic degradation; 4) no physical barrier exists for urate diffusion, and thus allow fast degradation of UA in blood and neutralizes the toxic by-product H2 O2 . In vivo results demonstrate that the biohybrids can effectively normalize the UA level of an acute hyperuricemia mouse model within 2 h and possess a longer elimination half-life (49.7 ± 4.9 h). They anticipate that their simple and general method that combines functional nanomaterials with living cell carriers will be a starting point for the development of innovative drug delivery systems.
Collapse
Affiliation(s)
- Zeyu Li
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Liecong Xue
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Junxian Yang
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510000, P. R. China
| | - Stefan Wuttke
- BCMaterials, Basque Center for Materials, UPV/EHU Science Park, Leioa, 48940, Spain
- IKERBASQUE, Basque Foundation for Science, Bilbao, 48009, Spain
| | - Peiying He
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Chuanyi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Haowei Yang
- China National Tobacco Corporation, No.55 South Yuetan Boulevard Xicheng District, Beijing, 100045, P. R. China
| | - Liang Zhou
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Jiangfan Cao
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Anna Sinelshchikova
- BCMaterials, Basque Center for Materials, UPV/EHU Science Park, Leioa, 48940, Spain
| | - Guansheng Zheng
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| | - Jimin Guo
- College of Materials Sciences and Engineering, Beijing University of Chemical Technology, Beijing, 100029, P. R. China
| | - Jiangguo Lin
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510000, P. R. China
| | - Qi Lei
- The Second Affiliated Hospital, State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy and Clinical Immunology, Guangzhou Medical University, Guangzhou, 510260, P.R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Kaisheng Liu
- Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020, P. R. China
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China
| |
Collapse
|
2
|
Noureddine A, Maestas-Olguin A, Tang L, Corman-Hijar JI, Olewine M, Krawchuck JA, Tsala Ebode J, Edeh C, Dang C, Negrete OA, Watt J, Howard T, Coker EN, Guo J, Brinker CJ. Future of Mesoporous Silica Nanoparticles in Nanomedicine: Protocol for Reproducible Synthesis, Characterization, Lipid Coating, and Loading of Therapeutics (Chemotherapeutic, Proteins, siRNA and mRNA). ACS Nano 2023; 17:16308-16325. [PMID: 37643407 DOI: 10.1021/acsnano.3c07621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/31/2023]
Abstract
Owing to their uniform and tunable particle size, pore size, and shape, along with their modular surface chemistry and biocompatibility, mesoporous silica nanoparticles (MSNs) have found extensive applications as nanocarriers to deliver therapeutic, diagnostic and combined "theranostic" cargos to cells and tissues. Although thoroughly investigated, MSN have garnered FDA approval for only one MSN system via oral administration. One possible reason is that there is no recognized, reproducible, and widely adopted MSN synthetic protocol, meaning not all MSNs are created equal in the laboratory nor in the eyes of the FDA. This manuscript provides the sol-gel and MSN research communities a reproducible, fully characterized synthetic protocol to synthesize MSNs and corresponding lipid-coated MSN delivery vehicles with predetermined particle size, pore size, and drug loading and release characteristics. By carefully articulating the step-by-step synthetic procedures and highlighting critical points and troubleshooting, augmented with videos and schematics, this Article will help researchers entering this rapidly expanding field to yield reliable results.
Collapse
Affiliation(s)
- Achraf Noureddine
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Angelea Maestas-Olguin
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Lien Tang
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, United States
| | - Jim I Corman-Hijar
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Biomedical Engineering Department, Pontifical Catholic University of Peru, San Miguel 15088, Peru
| | - Marian Olewine
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jacob A Krawchuck
- Center for Integrated Nanotechnologies, Sandia National Laboratories, Albuquerque, New Mexico 87123, United States
| | - Johanna Tsala Ebode
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Chuzube Edeh
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Caleb Dang
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Oscar A Negrete
- Systems Biology Department, Sandia National Laboratories, Livermore, California 94550 United States
| | - John Watt
- Center for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, United States
| | - Tamara Howard
- Department of Cell Biology & Physiology, UNM School of Medicine, Albuquerque, New Mexico 87131, United States
| | - Eric N Coker
- Electronic, Optical, and Nano Materials, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | - Jimin Guo
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- College of Materials Sciences and Engineering, Beijing University of Chemical Technology, Beijing, 100029 China
| | - C Jeffrey Brinker
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
3
|
Staquicini DI, Cardó-Vila M, Rotolo JA, Staquicini FI, Tang FHF, Smith TL, Ganju A, Schiavone C, Dogra P, Wang Z, Cristini V, Giordano RJ, Ozawa MG, Driessen WHP, Proneth B, Souza GR, Brinker LM, Noureddine A, Snider AJ, Canals D, Gelovani JG, Petrache I, Tuder RM, Obeid LM, Hannun YA, Kolesnick RN, Brinker CJ, Pasqualini R, Arap W. Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands. Proc Natl Acad Sci U S A 2023; 120:e2220269120. [PMID: 37579172 PMCID: PMC10450669 DOI: 10.1073/pnas.2220269120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Accepted: 06/21/2023] [Indexed: 08/16/2023] Open
Abstract
The vascular endothelium from individual organs is functionally specialized, and it displays a unique set of accessible molecular targets. These serve as endothelial cell receptors to affinity ligands. To date, all identified vascular receptors have been proteins. Here, we show that an endothelial lung-homing peptide (CGSPGWVRC) interacts with C16-ceramide, a bioactive sphingolipid that mediates several biological functions. Upon binding to cell surfaces, CGSPGWVRC triggers ceramide-rich platform formation, activates acid sphingomyelinase and ceramide production, without the associated downstream apoptotic signaling. We also show that the lung selectivity of CGSPGWVRC homing peptide is dependent on ceramide production in vivo. Finally, we demonstrate two potential applications for this lipid vascular targeting system: i) as a bioinorganic hydrogel for pulmonary imaging and ii) as a ligand-directed lung immunization tool against COVID-19. Thus, C16-ceramide is a unique example of a lipid-based receptor system in the lung vascular endothelium targeted in vivo by circulating ligands such as CGSPGWVRC.
Collapse
Affiliation(s)
- Daniela I. Staquicini
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ07103
| | - Marina Cardó-Vila
- University of Arizona Cancer Center, University of Arizona, Tucson, AZ85724
- Department of Otolaryngology-Head and Neck Surgery, University of Arizona, Tucson, AZ85724
| | - Jimmy A. Rotolo
- Department of Molecular Pharmacology, Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center, New York, NY10021
| | - Fernanda I. Staquicini
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ07103
| | - Fenny H. F. Tang
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ07103
| | - Tracey L. Smith
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ07103
| | - Aditya Ganju
- Department of Molecular Pharmacology, Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center, New York, NY10021
| | - Carmine Schiavone
- Department of Medicine, Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX77030
| | - Prashant Dogra
- Department of Medicine, Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX77030
- Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY10065
| | - Zhihui Wang
- Department of Medicine, Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX77030
- Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY10065
- Neal Cancer Center, Houston Methodist Research Institute, Houston, TX77030
| | - Vittorio Cristini
- Department of Medicine, Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX77030
- Neal Cancer Center, Houston Methodist Research Institute, Houston, TX77030
- Department of Imaging Physics, The University of Texas M.D. Anderson Cancer Center, Houston, TX77030
- Physiology, Biophysics and Systems Biology Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY10065
| | - Ricardo J. Giordano
- Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP05508, Brazil
| | - Michael G. Ozawa
- Department of Pathology, Stanford University School of Medicine, Stanford, CA94305
| | - Wouter H. P. Driessen
- David H. Koch Center and Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX77030
| | - Bettina Proneth
- Institute of Metabolism and Cell Death, Helmholtz Zentrum Muenchen, Muenchen, Neuherberg85764, Germany
| | - Glauco R. Souza
- David H. Koch Center and Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX77030
| | - Lina M. Brinker
- Department of Chemical and Biological Engineering, Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM87131
| | - Achraf Noureddine
- Department of Chemical and Biological Engineering, Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM87131
| | - Ashley J. Snider
- Stony Brook Cancer Center, Stony Brook University Hospital and Department of Medicine, Renaissance School of Medicine, Stony Brook University, Brook for Brookhaven, Suffolk County, NY11794
| | - Daniel Canals
- Stony Brook Cancer Center, Stony Brook University Hospital and Department of Medicine, Renaissance School of Medicine, Stony Brook University, Brook for Brookhaven, Suffolk County, NY11794
| | - Juri G. Gelovani
- Office of the Provost, United Arab Emirates University, Al Ain, Abu Dhabi15551, UAE
| | - Irina Petrache
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO80206
- Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO80045
| | - Rubin M. Tuder
- Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO80045
| | - Lina M. Obeid
- Stony Brook Cancer Center, Stony Brook University Hospital and Department of Medicine, Renaissance School of Medicine, Stony Brook University, Brook for Brookhaven, Suffolk County, NY11794
| | - Yusuf A. Hannun
- Stony Brook Cancer Center, Stony Brook University Hospital and Department of Medicine, Renaissance School of Medicine, Stony Brook University, Brook for Brookhaven, Suffolk County, NY11794
- Stony Brook Cancer Center, Stony Brook University Hospital and Departments of Biochemistry and Pathology, Renaissance School of Medicine, Stony Brook University, Brookhaven, NY11794
| | - Richard N. Kolesnick
- Department of Molecular Pharmacology, Laboratory of Signal Transduction, Memorial Sloan-Kettering Cancer Center, New York, NY10021
| | - C. Jeffrey Brinker
- Department of Chemical and Biological Engineering, Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM87131
| | - Renata Pasqualini
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ07103
| | - Wadih Arap
- Rutgers Cancer Institute of New Jersey, Newark, NJ07101
- Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ07103
| |
Collapse
|
4
|
Lei Q, Sun Y, Huang J, Liu W, Zhan X, Yin W, Guo S, Sinelshchikova A, Brinker CJ, He Z, Guo J, Wuttke S, Zhu W. Dimensional Reduction of Metal−Organic Frameworks for Enhanced Cryopreservation of Red Blood Cells. Angew Chem Int Ed Engl 2023. [DOI: 10.1002/ange.202217374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]
|
5
|
Lei Q, Sun Y, Huang J, Liu W, Zhan X, Yin W, Guo S, Sinelshchikova A, Brinker CJ, He Z, Guo J, Wuttke S, Zhu W. Dimensional Reduction of Metal-Organic Frameworks for Enhanced Cryopreservation of Red Blood Cells. Angew Chem Int Ed Engl 2023; 62:e202217374. [PMID: 36988087 DOI: 10.1002/anie.202217374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 03/27/2023] [Accepted: 03/28/2023] [Indexed: 03/30/2023]
Abstract
To increase the red blood cell (RBC) cryopreservation efficiency by metal-organic frameworks (MOFs), a dimensional reduction approach has been proposed. Namely 3D MOF nanoparticles are progressively reduced to 2D ultra-thin metal-organic layers (MOLs). We found that 2D MOLs are beneficial for enhanced interactions of interfacial hydrogen-bonded water network and increased utilization of inner ordered structures, due to the higher surface-to-volume ratio. Specifically, a series of hafnium (Hf)-based 2D MOLs with different thickness (monolayer to stacked multilayers) and density of hydrogen bonding sites have been synthesized. Both ice recrystallization inhibition activity (IRI) and RBCs cryopreservation assay confirm the pronounced better IRI activity and excellent cell recovery efficiency (up to ~63% at a very low concentration of 0.7 mg mL-1) of thin-layered Hf-MOLs compared to their 3D counterparts, thereby verifying the dimensional reduction strategy to improved cryoprotectant behaviors.
Collapse
Affiliation(s)
- Qi Lei
- South China University of Technology, School of Biology and Biological Engineering, 510006, Guangzhou, CHINA
| | - Yaqian Sun
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | - Junda Huang
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | - Wei Liu
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | - Xiaolong Zhan
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | - Wenxiang Yin
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | - Sishi Guo
- South China University of Technology, School of Biology and Biological Engineering, 510006, guangzhou, CHINA
| | | | - C Jeffrey Brinker
- The University of New Mexico, Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, 87131, Albuquerque, UNITED STATES
| | - Zhiyuan He
- Beijing Institute of Technology, School of Materials Science and Engineering, 100081, Beijing, CHINA
| | - Jimin Guo
- The University of New Mexico, Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, 87131, Albuquerque, UNITED STATES
| | - Stefan Wuttke
- Basque Foundation for Science: Ikerbasque, Ikerbasque, 48009, Bilbao, SPAIN
| | - Wei Zhu
- South China University of Technology, MOE International Joint Research Laboratory on Synthetic Biology and Medicines,, 510006, Guangzhou, CHINA
| |
Collapse
|
6
|
Buriak JM, Akinwande D, Artzi N, Brinker CJ, Burrows C, Chan WCW, Chen C, Chen X, Chhowalla M, Chi L, Chueh W, Crudden CM, Di Carlo D, Glotzer SC, Hersam MC, Ho D, Hu TY, Huang J, Javey A, Kamat PV, Kim ID, Kotov NA, Lee TR, Lee YH, Li Y, Liz-Marzán LM, Mulvaney P, Narang P, Nordlander P, Oklu R, Parak WJ, Rogach AL, Salanne M, Samorì P, Schaak RE, Schanze KS, Sekitani T, Skrabalak S, Sood AK, Voets IK, Wang S, Wang S, Wee ATS, Ye J. Best Practices for Using AI When Writing Scientific Manuscripts. ACS Nano 2023; 17:4091-4093. [PMID: 36848601 DOI: 10.1021/acsnano.3c01544] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
|
7
|
Gonzalez Porras MA, Gransee HM, Denton TT, Shen D, Webb KL, Brinker CJ, Noureddine A, Sieck GC, Mantilla CB. CTB-targeted protocells enhance ability of lanthionine ketenamine analogs to induce autophagy in motor neuron-like cells. Sci Rep 2023; 13:2581. [PMID: 36781993 PMCID: PMC9925763 DOI: 10.1038/s41598-023-29437-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Accepted: 02/03/2023] [Indexed: 02/15/2023] Open
Abstract
Impaired autophagy, a cellular digestion process that eliminates proteins and damaged organelles, has been implicated in neurodegenerative diseases, including motor neuron disorders. Motor neuron targeted upregulation of autophagy may serve as a promising therapeutic approach. Lanthionine ketenamine (LK), an amino acid metabolite found in mammalian brain tissue, activates autophagy in neuronal cell lines. We hypothesized that analogs of LK can be targeted to motor neurons using nanoparticles to improve autophagy flux. Using a mouse motor neuron-like hybrid cell line (NSC-34), we tested the effect of three different LK analogs on autophagy modulation, either alone or loaded in nanoparticles. For fluorescence visualization of autophagy flux, we used a mCherry-GFP-LC3 plasmid reporter. We also evaluated protein expression changes in LC3-II/LC3-I ratio obtained by western blot, as well as presence of autophagic vacuoles per cell obtained by electron microscopy. Delivering LK analogs with targeted nanoparticles significantly enhanced autophagy flux in differentiated motor neuron-like cells compared to LK analogs alone, suggesting the need of a delivery vehicle to enhance their efficacy. In conclusion, LK analogs loaded in nanoparticles targeting motor neurons constitute a promising treatment option to induce autophagy flux, which may serve to mitigate motor neuron degeneration/loss and preserve motor function in motor neuron disease.
Collapse
Affiliation(s)
- Maria A Gonzalez Porras
- Department of Biomedical Engineering, University of Texas at San Antonio, San Antonio, TX, USA
| | - Heather M Gransee
- Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, MN, USA
| | - Travis T Denton
- Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University Health Sciences Spokane, Spokane, WA, USA
- Department of Translational Medicine and Physiology, Elson S. Floyd, College of Medicine, Washington State University Health Sciences Spokane, Spokane, WA, USA
- Steve Gleason Institute for Neuroscience, Washington State University Health Sciences Spokane, Spokane, WA, USA
| | - Dunxin Shen
- Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University Health Sciences Spokane, Spokane, WA, USA
| | - Kevin L Webb
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM, USA
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM, USA
| | - Achraf Noureddine
- Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM, USA
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA
| | - Gary C Sieck
- Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, MN, USA
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
| | - Carlos B Mantilla
- Department of Anesthesiology & Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
- MB2-758, St Mary's Hospital, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
| |
Collapse
|
8
|
Qian F, Huang Z, Zhong H, Lei Q, Ai Y, Xie Z, Zhang T, Jiang B, Zhu W, Sheng Y, Hu J, Brinker CJ. Analysis and Biomedical Applications of Functional Cargo in Extracellular Vesicles. ACS Nano 2022; 16:19980-20001. [PMID: 36475625 DOI: 10.1021/acsnano.2c11298] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Extracellular vesicles (EVs) can facilitate essential communication among cells in a range of pathophysiological conditions including cancer metastasis and progression, immune regulation, and neuronal communication. EVs are membrane-enclosed vesicles generated through endocytic origin and contain many cellular components, including proteins, lipids, nucleic acids, and metabolites. Over the past few years, the intravesicular content of EVs has proven to be a valuable biomarker for disease diagnostics, involving cancer, cardiovascular diseases, and central nervous system diseases. This review aims to provide insight into EV biogenesis, composition, function, and isolation, present a comprehensive overview of emerging techniques for EV cargo analysis, highlighting their major technical features and limitations, and summarize the potential role of EV cargos as biomarkers in disease diagnostics. Further, progress and remaining challenges will be discussed for clinical diagnostic outlooks.
Collapse
Affiliation(s)
- Feiyang Qian
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Zena Huang
- Yunkang School of Medicine and Health, Nanfang College, Guangzhou 510970, P.R. China
| | - Hankang Zhong
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China
| | - Yiru Ai
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Zihui Xie
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Tenghua Zhang
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Bowen Jiang
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China
| | - Yan Sheng
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - Jiaming Hu
- MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, P.R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
9
|
Butler K, Brinker CJ, Leong HS. Bridging the In Vitro to In Vivo gap: Using the Chick Embryo Model to Accelerate Nanoparticle Validation and Qualification for In Vivo studies. ACS Nano 2022; 16:19626-19650. [PMID: 36453753 PMCID: PMC9799072 DOI: 10.1021/acsnano.2c03990] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Accepted: 10/17/2022] [Indexed: 06/17/2023]
Abstract
We postulate that nanoparticles (NPs) for use in therapeutic applications have largely not realized their clinical potential due to an overall inability to use in vitro results to predict NP performance in vivo. The avian embryo and associated chorioallantoic membrane (CAM) has emerged as an in vivo preclinical model that bridges the gap between in vitro and in vivo, enabling rapid screening of NP behavior under physiologically relevant conditions and providing a rapid, accessible, economical, and more ethical means of qualifying nanoparticles for in vivo use. The CAM is highly vascularized and mimics the diverging/converging vasculature of the liver, spleen, and lungs that serve as nanoparticle traps. Intravital imaging of fluorescently labeled NPs injected into the CAM vasculature enables immediate assessment and quantification of nano-bio interactions at the individual NP scale in any tissue of interest that is perfused with a microvasculature. In this review, we highlight how utilization of the avian embryo and its CAM as a preclinical model can be used to understand NP stability in blood and tissues, extravasation, biocompatibility, and NP distribution over time, thereby serving to identify a subset of NPs with the requisite stability and performance to introduce into rodent models and enabling the development of structure-property relationships and NP optimization without the sacrifice of large populations of mice or other rodents. We then review how the chicken embryo and CAM model systems have been used to accelerate the development of NP delivery and imaging agents by allowing direct visualization of targeted (active) and nontargeted (passive) NP binding, internalization, and cargo delivery to individual cells (of relevance for the treatment of leukemia and metastatic cancer) and cellular ensembles (e.g., cancer xenografts of interest for treatment or imaging of cancer tumors). We conclude by showcasing emerging techniques for the utilization of the CAM in future nano-bio studies.
Collapse
Affiliation(s)
- Kimberly
S. Butler
- Molecular
and Microbiology, Sandia National Laboratories, Albuquerque, New Mexico 87123, United States
| | - C. Jeffrey Brinker
- Department
of Chemical and Biological Engineering and the Comprehensive Cancer
Center, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Hon Sing Leong
- Department
of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto M5G 1L7, Canada
- Biological
Sciences Platform, Sunnybrook Hospital, Toronto M4N 3M5, Canada
| |
Collapse
|
10
|
Hu T, Brinker CJ, Chan WCW, Chen C, Chen X, Ho D, Kataoka K, Kotov NA, Liz-Marzán LM, Nel AE, Parak WJ, Stevens M. Publishing Translational Research of Nanomedicine in ACS Nano. ACS Nano 2022; 16:17479-17481. [PMID: 36440801 DOI: 10.1021/acsnano.2c10967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
|
11
|
Zhou L, Lei Q, Guo J, Gao Y, Shi J, Yu H, Yin W, Cao J, Xiao B, Andreo J, Ettlinger R, Jeffrey Brinker C, Wuttke S, Zhu W. Long-term whole blood DNA preservation by cost-efficient cryosilicification. Nat Commun 2022; 13:6265. [PMID: 36270991 PMCID: PMC9587218 DOI: 10.1038/s41467-022-33759-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2022] [Accepted: 09/30/2022] [Indexed: 12/25/2022] Open
Abstract
Deoxyribonucleic acid (DNA) is the blueprint of life, and cost-effective methods for its long-term storage could have many potential benefits to society. Here we present the method of in situ cryosilicification of whole blood cells, which allows long-term preservation of DNA. Importantly, our straightforward approach is inexpensive, reliable, and yields cryosilicified samples that fulfill the essential criteria for safe, long-term DNA preservation, namely robustness against external stressors, such as radical oxygen species or ultraviolet radiation, and long-term stability in humid conditions at elevated temperatures. Our approach could enable the room temperature storage of genomic information in book-size format for more than one thousand years (thermally equivalent), costing only 0.5 $/person. Additionally, our demonstration of 3D-printed DNA banking artefacts, could potentially allow 'artificial fossilization'.
Collapse
Affiliation(s)
- Liang Zhou
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Qi Lei
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Jimin Guo
- grid.266832.b0000 0001 2188 8502Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131 USA
| | - Yuanyuan Gao
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Jianjun Shi
- grid.459319.30000 0001 0175 0741Science and Technology on Advanced Functional Composites Technology, Aerospace Research Institute of Materials & Processing Technology, Beijing, 100076 P. R. China
| | - Hong Yu
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Wenxiang Yin
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Jiangfan Cao
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Botao Xiao
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| | - Jacopo Andreo
- grid.473251.60000 0004 6475 7301BCMaterials, Basque Center for Materials, UPV/EHU Science Park, 48940 Leioa, Spain
| | - Romy Ettlinger
- grid.11914.3c0000 0001 0721 1626School of Chemistry, University of St. Andrews, St. Andrews, United Kingdom
| | - C. Jeffrey Brinker
- grid.266832.b0000 0001 2188 8502Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131 USA
| | - Stefan Wuttke
- grid.473251.60000 0004 6475 7301BCMaterials, Basque Center for Materials, UPV/EHU Science Park, 48940 Leioa, Spain ,grid.424810.b0000 0004 0467 2314Ikerbasque, Basque Foundation for Science, Bilbao, Spain
| | - Wei Zhu
- grid.79703.3a0000 0004 1764 3838MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006 P. R. China
| |
Collapse
|
12
|
He P, Lei Q, Yang B, Shang T, Shi J, Ouyang Q, Wang W, Xue L, Kong F, Li Z, Huang J, Liu L, Guo J, Brinker CJ, Liu K, Zhu W. Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy. ACS Nano 2022; 16:13919-13932. [PMID: 36082976 DOI: 10.1021/acsnano.2c02965] [Citation(s) in RCA: 19] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
The triple-negative breast cancer (TNBC) microenvironment makes a feature of aberrant vasculature, high interstitial pressure, and compact extracellular matrix, which combine to reduce the delivery and penetration of therapeutic agents, bringing about incomplete elimination of cancer cells. Herein, employing the tumor penetration strategy of size-shrinkage combined with ligand modification, we constructed a photothermal nanocluster for cascaded deep penetration in tumor parenchyma and efficient eradication of TNBC cells. In our approach, the photothermal agent indocyanine green (ICG) is laded in human serum albumin (HSA), which is cross-linked by a thermally labile azo linker (VA057) and then further modified with a tumor homing/penetrating tLyP-1 peptide (HP), resulting in a TNBC-targeting photothermal-responsive size-switchable albumin nanocluster (ICG@HSA-Azo-HP). Aided by the enhanced permeability and retention effect and guidance of HP, the ca. 149 nm nanoclusters selectively accumulate in the tumor site and then, upon mild irradiation with the 808 nm laser, disintegrate into 11 nm albumin fractions that possess enhanced intratumoral diffusion ability. Meanwhile, HP initiates the CendR pathway among the nutrient-deficient tumor cells and facilitates the transcellular delivery of the nanocluster and its disintegrated fractions for subsequent therapy. By employing this size-shrinkage and peptide-initiated transcytosis strategy, ICG@HSA-Azo-HP possesses excellent penetration capabilities and shows extensive penetration depth in three-dimensional multicellular tumor spheroids after irradiation. Moreover, with a superior photothermal conversion effect, the tumor-penetrating nanocluster can implement effective photothermal therapy throughout the tumor tissue under a second robust irradiation. Both in vivo orthotopic and ectopic TNBC therapy confirmed the efficient tumor inhibition of ICG@HSA-Azo-HP after dual-stage irradiation. The synergistic penetration strategy of on-demanded size-shrinkage and ligand guidance accompanied by clinically feasible NIR irradiation provides a promising approach for deep-penetrating TNBC therapy.
Collapse
Affiliation(s)
- Peiying He
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Bin Yang
- The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou511436, People's Republic of China
| | - Tongyi Shang
- The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou511436, People's Republic of China
| | - Jianjun Shi
- Science and Technology on Advanced Functional Composites Technology, Aerospace Research Institute of Materials & Processing Technology, Beijing100076, People's Republic of China
| | - Qing Ouyang
- Department of Hepatobiliary Surgery and Liver Transplant Center, The General Hospital of Southern Theater, Guangzhou510010, People's Republic of China
| | - Wei Wang
- Science and Technology on Advanced Functional Composites Technology, Aerospace Research Institute of Materials & Processing Technology, Beijing100076, People's Republic of China
| | - Liecong Xue
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Fanhui Kong
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Zeyu Li
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Junda Huang
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| | - Lihan Liu
- Department of Pharmaceutical Sciences and Guangdong Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou510515, People's Republic of China
| | - Jimin Guo
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico87131, United States
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico87131, United States
| | - Kaisheng Liu
- Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen518020, People's Republic of China
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou510006, People's Republic of China
| |
Collapse
|
13
|
Kotov NA, Akinwande D, Brinker CJ, Buriak JM, Chan WCW, Chen X, Chhowalla M, Chueh W, Glotzer SC, Gogotsi Y, Hersam MC, Ho D, Hu T, Javey A, Kagan CR, Kataoka K, Kim ID, Lee ST, Lee YH, Liz-Marzán LM, Millstone JE, Mulvaney P, Nel AE, Nordlander P, Parak WJ, Penner RM, Rogach AL, Salanne M, Schaak RE, Sood AK, Stevens M, Tsukruk V, Wee ATS, Voets I, Weil T, Weiss PS. Tanks and Truth. ACS Nano 2022; 16:4975-4976. [PMID: 35315638 DOI: 10.1021/acsnano.2c02602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
|
14
|
Guo J, Amini S, Lei Q, Ping Y, Agola JO, Wang L, Zhou L, Cao J, Franco S, Noureddine A, Miserez A, Zhu W, Brinker CJ. Robust and Long-Term Cellular Protein and Enzymatic Activity Preservation in Biomineralized Mammalian Cells. ACS Nano 2022; 16:2164-2175. [PMID: 35143166 DOI: 10.1021/acsnano.1c08103] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Preservation of evolved biological structure and function in robust engineering materials is of interest for storage of biological samples before diagnosis and development of vaccines, sensors, and enzymatic reactors and has the potential to avoid cryopreservation and its associated cold-chain issues. Here, we demonstrate that "freezing cells in amorphous silica" is a powerful technique for long-term preservation of whole mammalian cell proteomic structure and function at room temperature. Biomimetic silicification employs the crowded protein microenvironment of mammalian cells as a catalytic framework to proximally transform monomeric silicic acid into silicates forming a nanoscopic silica shell over all biomolecular interfaces. Silicification followed by dehydration preserves and passivates proteomic information within a nanoscale thin silica coating that exhibits size selective permeability (<3.6 nm), preventing protein leaching and protease degradation of cellular contents, while providing access of small molecular constituents for cellular enzymatic reaction. Exposure of dehydrated silicified cells to mild etchant or prolonged hydrolysis removes the silica, completely rerevealing biomolecular components and restoring their accessibility and functionality.
Collapse
Affiliation(s)
- Jimin Guo
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Shahrouz Amini
- Center for Biomimetic Sensor Science, School of Materials Science and Engineering, Nanyang Technological University (NTU), 50 Nanyang Drive, Singapore, 637553, Singapore
- Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, 14476 Potsdam, Germany
| | - Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China
| | - Yuan Ping
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, People's Republic of China
| | - Jacob Ongudi Agola
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Lu Wang
- Department of Biochemistry and Molecular Biology, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Liang Zhou
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China
| | - Jiangfan Cao
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China
| | - Stefan Franco
- Department of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Achraf Noureddine
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Ali Miserez
- Center for Biomimetic Sensor Science, School of Materials Science and Engineering, Nanyang Technological University (NTU), 50 Nanyang Drive, Singapore, 637553, Singapore
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, People's Republic of China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
15
|
El Hayek E, Medina S, Guo J, Noureddine A, Zychowski KE, Hunter R, Velasco CA, Wiesse M, Maestas-Olguin A, Brinker CJ, Brearley A, Spilde M, Howard T, Lauer FT, Herbert G, Ali AM, Burchiel S, Campen MJ, Cerrato JM. Uptake and Toxicity of Respirable Carbon-Rich Uranium-Bearing Particles: Insights into the Role of Particulates in Uranium Toxicity. Environ Sci Technol 2021; 55:9949-9957. [PMID: 34235927 PMCID: PMC8413144 DOI: 10.1021/acs.est.1c01205] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Abstract
Particulate matter (PM) presents an environmental health risk for communities residing close to uranium (U) mine sites. However, the role of the particulate form of U on its cellular toxicity is still poorly understood. Here, we investigated the cellular uptake and toxicity of C-rich U-bearing particles as a model organic particulate containing uranyl citrate over a range of environmentally relevant concentrations of U (0-445 μM). The cytotoxicity of C-rich U-bearing particles in human epithelial cells (A549) was U-dose-dependent. No cytotoxic effects were detected with soluble U doses. Carbon-rich U-bearing particles with a wide size distribution (<10 μm) presented 2.7 times higher U uptake into cells than the particles with a narrow size distribution (<1 μm) at 100 μM U concentration. TEM-EDS analysis identified the intracellular translocation of clusters of C-rich U-bearing particles. The accumulation of C-rich U-bearing particles induced DNA damage and cytotoxicity as indicated by the increased phosphorylation of the histone H2AX and cell death, respectively. These findings reveal the toxicity of the particulate form of U under environmentally relevant heterogeneous size distributions. Our study opens new avenues for future investigations on the health impacts resulting from environmental exposures to the particulate form of U near mine sites.
Collapse
Affiliation(s)
- Eliane El Hayek
- Department of Chemistry and Chemical Biology, MSC03 2060, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - Sebastian Medina
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
- Department of Biology, New Mexico Highlands University, Las Vegas, New Mexico 87701, United States
| | - Jimin Guo
- Department of Chemical and Biological Engineering, MSC01 1120, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Internal Medicine, Molecular Medicine, MSC08 4720, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Achraf Noureddine
- Department of Chemical and Biological Engineering, MSC01 1120, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Katherine E Zychowski
- Department of Biobehavioral Health and Data Sciences, MSC09 5350, University of New Mexico College of Nursing, Albuquerque, New Mexico 87106, United States
| | - Russell Hunter
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - Carmen A Velasco
- Department of Civil Engineering, MSC01 1070, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Chemical Engineering Faculty, Central University of Ecuador, Ciudad Universitaria, Ritter s/n & Bolivia, P.O. Box 17-01-3972, Quito 170129, Ecuador
| | - Marco Wiesse
- Department of Civil Engineering, MSC01 1070, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Angelea Maestas-Olguin
- Department of Chemical and Biological Engineering, MSC01 1120, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - C Jeffrey Brinker
- Department of Chemical and Biological Engineering, MSC01 1120, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Adrian Brearley
- Department of Earth and Planetary Sciences, MSC03 2040, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Michael Spilde
- Department of Earth and Planetary Sciences, MSC03 2040, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Tamara Howard
- Department of Cell Biology and Physiology, MSC08 4750, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Fredine T Lauer
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - Guy Herbert
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - Abdul Mehdi Ali
- Department of Earth and Planetary Sciences, MSC03 2040, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Scott Burchiel
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - Matthew J Campen
- Department of Pharmaceutical Sciences, MSC09 5360, University of New Mexico, College of Pharmacy, Albuquerque, New Mexico 87131, United States
| | - José M Cerrato
- Department of Civil Engineering, MSC01 1070, University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
16
|
Huang J, Guo J, Zhou L, Zheng G, Cao J, Li Z, Zhou Z, Lei Q, Brinker CJ, Zhu W. Advanced Nanomaterials-Assisted Cell Cryopreservation: A Mini Review. ACS Appl Bio Mater 2021; 4:2996-3014. [PMID: 35014388 DOI: 10.1021/acsabm.1c00105] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Cell cryopreservation is of vital significance both for transporting and storing cells before experimental/clinical use. Cryoprotectants (CPAs) are necessary additives in the preserving medium in cryopreservation, preventing cells from freeze-thaw injuries. Traditional organic solvents have been widely used in cell cryopreservation for decades. Given the obvious damage to cells due to their undesirable cytotoxicity and the burdensome post-thaw washing cycles before use, traditional CPAs are more and more likely to be replaced by modern ones with lower toxicity, less processing, and higher efficiency. As materials science thrives, nanomaterials are emerging to serve as potent vehicles for delivering nontoxic CPAs or inherent CPAs comparable to or even superior to conventional ones. This review will introduce some advanced nanomaterials (e.g., organic/inorganic nanoCPAs, nanodelivery systems) utilized for cell cryopreservation, providing broader insights into this developing field.
Collapse
Affiliation(s)
- Junda Huang
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States.,Department of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Liang Zhou
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Guansheng Zheng
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Jiangfan Cao
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Zeyu Li
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Zhuang Zhou
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| |
Collapse
|
17
|
Abstract
In nature, biosilicification directs the formation of elaborate amorphous silica exoskeletons that provide diatoms mechanically strong, chemically inert, non-decomposable silica armor conferring chemical and thermal stability as well as resistance to microbial attack, without changing the optical transparency or adversely effecting nutrient and waste exchange required for growth. These extraordinary silica/cell biocomposites have inspired decades of biomimetic research aimed at replication of diatoms' hierarchically organized exoskeletons, immobilization of cells or living organisms within silica matrices and coatings to protect them against harmful external stresses, genetic re-programming of cellular functions by virtue of physico-chemical confinement within silica, cellular integration into devices, and endowment of cells with non-native, abiotic properties through facile silica functionalization. In this Perspective, we focus our discussions on the development and concomitant challenges of bioinspired cell silicification ranging from "cells encapsulated within 3D silica matrices" and "cells encapsulated within 2D silica shells" to extra- and intracellular silica replication, wherein all biomolecular interfaces are encased within nanoscopic layers of amorphous silica. We highlight notable examples of advances in the science and technology of biosilicification and consider challenges to advancing the field, where we propose cellular "mineralization" with arbitrary nanoparticle exoskeletons as a generalizable means to impart limitless abiotic properties and functions to cells, and, based on the interchangeability of water and silicic acid and analogies between amorphous ice and amorphous silica, we consider "freezing" cells within amorphous silica as an alternative to cryo-preservation.
Collapse
Affiliation(s)
- Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States.,Department of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Fanhui Kong
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Jiangfan Cao
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Lu Wang
- Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
18
|
Lei Q, Guo J, Arreguin-Martinez E, Shi J, Brinker CJ, Zhu W. Synthesis of Polyhedral Metal-Organic Framework@Mesoporous Silica Hybrid Nanocomposites with Branched Shapes. ACS Appl Bio Mater 2021; 4:1221-1228. [PMID: 35014475 DOI: 10.1021/acsabm.0c01518] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The structural modulation of multicompartment porous nanomaterials is one of the major challenges of nanoscience. Herein, by utilizing the polyhedral effects/characteristics of metal-organic frameworks (MOFs), we present a versatile approach to construct MOF-organosilica hybrid branched nanocomposites with MOF cores, SiO2 shells, and periodic mesoporous organosilica (PMO) branches. The morphology, structure, and functions of the obtained hybrid nanocomposites can be facilely modulated by varying particle size, shape, or crystalline structures of the MOF cores. Specifically, these branched multicompartment porous nanoparticles exhibit evasion behaviors in epithelial cells compared with macrophage cells, which may endow them great potential as a vehicle for immunotherapy.
Collapse
Affiliation(s)
- Qi Lei
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| | - Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, the University of New Mexico, Albuquerque, New Mexico 87131, United States.,Department of Internal Medicine, Molecular Medicine, the University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Esmeralda Arreguin-Martinez
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, the University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jianjun Shi
- Science and Technology on Advanced Functional Composites Technology, Aerospace Research Institute of Materials & Processing Technology, Beijing 100076, P. R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, the University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Wei Zhu
- MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China
| |
Collapse
|
19
|
Noureddine A, Maestas-Olguin A, Saada EA, LaBauve AE, Agola JO, Baty KE, Howard T, Sabo JK, Espinoza CRS, Doudna JA, Schoeniger JS, Butler KS, Negrete OA, Brinker CJ, Serda RE. Corrigendum to "Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery" Acta Biomaterialia (2020), 114, 358-368. Acta Biomater 2021; 121:764. [PMID: 33309186 DOI: 10.1016/j.actbio.2020.11.038] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- Achraf Noureddine
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States.
| | - Angelea Maestas-Olguin
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States
| | - Edwin A Saada
- Department of Systems Biology, Sandia National Laboratories, Livermore, CA, United States
| | - Annette E LaBauve
- Department of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, United States
| | - Jacob O Agola
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States
| | - Keoni E Baty
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States
| | - Tamara Howard
- Cell Biology and Physiology, University of New Mexico Health Science Center, Albuquerque, NM, United States
| | - Jennifer K Sabo
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States
| | - Cindy R Sandoval Espinoza
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States
| | - Jennifer A Doudna
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States
| | - Joseph S Schoeniger
- Department of Systems Biology, Sandia National Laboratories, Livermore, CA, United States
| | - Kimberly S Butler
- Department of Nanobiology, Sandia National Laboratories, Albuquerque, NM, United States
| | - Oscar A Negrete
- Department of Biotechnology and Bioengineering, Sandia National Laboratories, Livermore, CA, United States
| | - C Jeffrey Brinker
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, United States.
| | - Rita E Serda
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States; Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, NM, United States; Department of Internal Medicine, Molecular Medicine, University of New Mexico Health Science Center, Albuquerque, NM, United States.
| |
Collapse
|
20
|
Brinker CJ, Butler KS, Garofalini SH. Are nearly free silanols a unifying structural determinant of silica particle toxicity? Proc Natl Acad Sci U S A 2020; 117:30006-30008. [PMID: 33188085 PMCID: PMC7720230 DOI: 10.1073/pnas.2021078117] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Affiliation(s)
- C Jeffrey Brinker
- Center for Micro-Engineered Materials, The University of New Mexico, Albuquerque, NM 87131;
- Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131
- Comprehensive Cancer Center, The University of New Mexico, Albuquerque, NM 87131
| | - Kimberly S Butler
- Department of Molecular and Microbiology, Sandia National Laboratories, Albuquerque, NM 87123
| | - Stephen H Garofalini
- Department of Materials Science and Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854
| |
Collapse
|
21
|
Martinez H, Martinez NJD, Guo J, Lujan VR, Depoy J, Brumbach MT, Brinker CJ, Bachand GD. Effects of Surface Chemistry and Topology on the Kinesin-Driven Motility of Microtubule Shuttles. ACS Appl Bio Mater 2020; 3:7908-7918. [DOI: 10.1021/acsabm.0c01035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- Haneen Martinez
- Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | | | - Jimin Guo
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Victoria R. Lujan
- Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | - Jessica Depoy
- Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | | | - C. Jeffrey Brinker
- Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - George D. Bachand
- Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| |
Collapse
|
22
|
Franco S, Noureddine A, Guo J, Keth J, Paffett ML, Brinker CJ, Serda RE. Direct Transfer of Mesoporous Silica Nanoparticles between Macrophages and Cancer Cells. Cancers (Basel) 2020; 12:cancers12102892. [PMID: 33050177 PMCID: PMC7600949 DOI: 10.3390/cancers12102892] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2020] [Revised: 10/04/2020] [Accepted: 10/06/2020] [Indexed: 02/07/2023] Open
Abstract
Macrophages line the walls of microvasculature, extending processes into the blood flow to capture foreign invaders, including nano-scale materials. Using mesoporous silica nanoparticles (MSNs) as a model nano-scale system, we show the interplay between macrophages and MSNs from initial uptake to intercellular trafficking to neighboring cells along microtubules. The nature of cytoplasmic bridges between cells and their role in the cell-to-cell transfer of nano-scale materials is examined, as is the ability of macrophages to function as carriers of nanomaterials to cancer cells. Both direct administration of nanoparticles and adoptive transfer of nanoparticle-loaded splenocytes in mice resulted in abundant localization of nanomaterials within macrophages 24 h post-injection, predominately in the liver. While heterotypic, trans-species nanomaterial transfer from murine macrophages to human HeLa cervical cancer cells or A549 lung cancer cells was robust, transfer to syngeneic 4T1 breast cancer cells was not detected in vitro or in vivo. Cellular connections and nanomaterial transfer in vivo were rich among immune cells, facilitating coordinated immune responses.
Collapse
Affiliation(s)
- Stefan Franco
- Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA; (S.F.); (J.G.); (J.K.)
| | - Achraf Noureddine
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA; (A.N.); (C.J.B.)
| | - Jimin Guo
- Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA; (S.F.); (J.G.); (J.K.)
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA; (A.N.); (C.J.B.)
| | - Jane Keth
- Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA; (S.F.); (J.G.); (J.K.)
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA; (A.N.); (C.J.B.)
| | - Michael L. Paffett
- Fluorescence Microscopy Shared Resource, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131, USA;
| | - C. Jeffrey Brinker
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA; (A.N.); (C.J.B.)
| | - Rita E. Serda
- Internal Medicine, University of New Mexico Health Science Center, Albuquerque, NM 87131, USA; (S.F.); (J.G.); (J.K.)
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131, USA; (A.N.); (C.J.B.)
- Correspondence: ; Tel.: +1-505−272−7698
| |
Collapse
|
23
|
Noureddine A, Maestas-Olguin A, Saada EA, LaBauve AE, Agola JO, Baty KE, Howard T, Sabo JK, Espinoza CRS, Doudna JA, Schoeniger JS, Butler KS, Negrete OA, Brinker CJ, Serda RE. Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery. Acta Biomater 2020; 114:358-368. [PMID: 32702530 DOI: 10.1016/j.actbio.2020.07.027] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2019] [Revised: 06/30/2020] [Accepted: 07/14/2020] [Indexed: 01/08/2023]
Abstract
CRISPR gene editing technology is strategically foreseen to control diseases by correcting underlying aberrant genetic sequences. In order to overcome drawbacks associated with viral vectors, the establishment of an effective non-viral CRISPR delivery vehicle has become an important goal for nanomaterial scientists. Herein, we introduce a monosized lipid-coated mesoporous silica nanoparticle (LC-MSN) delivery vehicle that enables both loading of CRISPR components [145 µg ribonucleoprotein (RNP) or 40 µg plasmid/mg nanoparticles] and efficient release within cancer cells (70%). The RNP-loaded LC-MSN exhibited 10% gene editing in both in vitro reporter cancer cell lines and in an in vivo Ai9-tdTomato reporter mouse model. The structural and chemical versatility of the mesoporous silica core and lipid coating along with framework dissolution-assisted cargo delivery open new prospects towards safe CRISPR component delivery and enhanced gene editing. STATEMENT OF SIGNIFICANCE: After the discovery of CRISPR gene-correcting technology in bacteria. The translation of this technology to mammalian cells may change the face of cancer therapy within the next years. This was first made possible through the use of viral vectors; however, such systems limit the safe translation of CRISPR into clinics because its difficult preparation and immunogenicity. Therefore, biocompatible non-viral nanoparticulate systems are required to successfully deliver CRISPR into cancer cells. The present study presents the use of biomimetic lipid-coated mesoporous silica nanoparticles showing successful delivery of CRISPR ribonucleoprotein and plasmid into HeLa cervical and A549 lung cancer cells as well as successful gene editing in mice brain.
Collapse
|
24
|
Guo J, Agola JO, Serda R, Franco S, Lei Q, Wang L, Minster J, Croissant JG, Butler KS, Zhu W, Brinker CJ. Biomimetic Rebuilding of Multifunctional Red Blood Cells: Modular Design Using Functional Components. ACS Nano 2020; 14:7847-7859. [PMID: 32391687 DOI: 10.1021/acsnano.9b08714] [Citation(s) in RCA: 45] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The design and synthesis of artificial materials that mimic the structures, mechanical properties, and ultimately functionalities of biological cells remains a current holy grail of materials science. Here, based on a silica cell bioreplication approach, we report the design and construction of synthetic rebuilt red blood cells (RRBCs) that fully mimic the broad properties of native RBCs: size, biconcave shape, deformability, oxygen-carrying capacity, and long circulation time. Four successive nanoscale processing steps (RBC bioreplication, layer-by-layer polymer deposition, and precision silica etching, followed by RBC ghost membrane vesicle fusion) are employed for RRBC construction. A panel of physicochemical analyses including zeta-potential measurement, fluorescence microscopy, and antibody-mediated agglutination assay proved the recapitulation of RBC shape, size, and membrane structure. Flow-based deformation studies carried out in a microfluidic blood capillary model confirmed the ability of RRBCs to deform and pass through small slits and reconstitute themselves in a manner comparable to native RBCs. Circulation studies of RRBCs conducted ex ovo in a chick embryo and in vivo in a mouse model demonstrated the requirement of both deformability and native cell membrane surface to achieve long-term circulation. To confer additional non-native functionalities to RRBCs, we developed modular procedures with which to load functional cargos such as hemoglobin, drugs, magnetic nanoparticles, and ATP biosensors within the RRBC interior to enable various functions, including oxygen delivery, therapeutic drug delivery, magnetic manipulation, and toxin biosensing and detection. Taken together, RRBCs represent a class of long-circulating RBC-inspired artificial hybrid materials with a broad range of potential applications.
Collapse
Affiliation(s)
- Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Internal Medicine, Molecular Medicine, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jacob Ongudi Agola
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Rita Serda
- Department of Internal Medicine, Molecular Medicine, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Stefan Franco
- Department of Internal Medicine, Molecular Medicine, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Qi Lei
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China
| | - Lu Wang
- Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Joshua Minster
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jonas G Croissant
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Kimberly S Butler
- Nanobiology Department, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | - Wei Zhu
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
25
|
Dogra P, Butner JD, Nizzero S, Ruiz Ramírez J, Noureddine A, Peláez MJ, Elganainy D, Yang Z, Le AD, Goel S, Leong HS, Koay EJ, Brinker CJ, Cristini V, Wang Z. Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020; 12:e1628. [PMID: 32314552 PMCID: PMC7507140 DOI: 10.1002/wnan.1628] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 02/06/2020] [Accepted: 02/15/2020] [Indexed: 12/13/2022]
Abstract
While plasma concentration kinetics has traditionally been the predictor of drug pharmacological effects, it can occasionally fail to represent kinetics at the site of action, particularly for solid tumors. This is especially true in the case of delivery of therapeutic macromolecules (drug-loaded nanomaterials or monoclonal antibodies), which can experience challenges to effective delivery due to particle size-dependent diffusion barriers at the target site. As a result, disparity between therapeutic plasma kinetics and kinetics at the site of action may exist, highlighting the importance of target site concentration kinetics in determining the pharmacodynamic effects of macromolecular therapeutic agents. Assessment of concentration kinetics at the target site has been facilitated by non-invasive in vivo imaging modalities. This allows for visualization and quantification of the whole-body disposition behavior of therapeutics that is essential for a comprehensive understanding of their pharmacokinetics and pharmacodynamics. Quantitative non-invasive imaging can also help guide the development and parameterization of mathematical models for descriptive and predictive purposes. Here, we present a review of the application of state-of-the-art imaging modalities for quantitative pharmacological evaluation of therapeutic nanoparticles and monoclonal antibodies, with a focus on their integration with mathematical models, and identify challenges and opportunities. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > in vivo Nanodiagnostics and Imaging Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.
Collapse
Affiliation(s)
- Prashant Dogra
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| | - Joseph D Butner
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| | - Sara Nizzero
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| | - Javier Ruiz Ramírez
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| | - Achraf Noureddine
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico, USA
| | - María J Peláez
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA.,Applied Physics Graduate Program, Rice University, Houston, Texas, USA
| | - Dalia Elganainy
- Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Zhen Yang
- Center for Bioenergetics, Houston Methodist Research Institute, Houston, Texas, USA
| | - Anh-Dung Le
- Nanoscience and Microsystems Engineering, University of New Mexico, Albuquerque, New Mexico, USA
| | - Shreya Goel
- Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Hon S Leong
- Biological Sciences Platform, Sunnybrook Research Institute, Toronto, Ontario, Canada.,Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
| | - Eugene J Koay
- Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - C Jeffrey Brinker
- Department of Chemical and Biological Engineering and UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico, USA
| | - Vittorio Cristini
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| | - Zhihui Wang
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
| |
Collapse
|
26
|
Story SD, Boggs S, Guiney LM, Ramesh M, Hersam MC, Brinker CJ, Walker SL. Aggregation morphology of planar engineered nanomaterials. J Colloid Interface Sci 2020; 561:849-853. [DOI: 10.1016/j.jcis.2019.11.067] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2019] [Revised: 11/15/2019] [Accepted: 11/16/2019] [Indexed: 01/12/2023]
|
27
|
Dogra P, Butner JD, Ruiz Ramírez J, Chuang YL, Noureddine A, Jeffrey Brinker C, Cristini V, Wang Z. A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery. Comput Struct Biotechnol J 2020; 18:518-531. [PMID: 32206211 PMCID: PMC7078505 DOI: 10.1016/j.csbj.2020.02.014] [Citation(s) in RCA: 47] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Revised: 02/14/2020] [Accepted: 02/22/2020] [Indexed: 02/07/2023] Open
Abstract
Towards clinical translation of cancer nanomedicine, it is important to systematically investigate the various parameters related to nanoparticle (NP) physicochemical properties, tumor characteristics, and inter-individual variability that affect the tumor delivery efficiency of therapeutic nanomaterials. Comprehensive investigation of these parameters using traditional experimental approaches is impractical due to the vast parameter space; mathematical models provide a more tractable approach to navigate through such a multidimensional space. To this end, we have developed a predictive mathematical model of whole-body NP pharmacokinetics and their tumor delivery in vivo, and have conducted local and global sensitivity analyses to identify the factors that result in low tumor delivery efficiency and high off-target accumulation of NPs. Our analyses reveal that NP degradation rate, tumor blood viscosity, NP size, tumor vascular fraction, and tumor vascular porosity are the key parameters in governing NP kinetics in the tumor interstitium. The impact of these parameters on tumor delivery efficiency of NPs is discussed, and optimal values for maximizing NP delivery are presented.
Collapse
Affiliation(s)
- Prashant Dogra
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Joseph D. Butner
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Javier Ruiz Ramírez
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Yao-li Chuang
- Department of Mathematics, California State University, Northridge, CA 91330, USA
| | - Achraf Noureddine
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87106, USA
| | - C. Jeffrey Brinker
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87106, USA
- UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM 87102, USA
| | - Vittorio Cristini
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Zhihui Wang
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
- Corresponding author at: Mathematics in Medicine Program, The Houston Methodist Research Institute, HMRI R8-122, 6670 Bertner Ave, Houston, TX 77030, USA.
| |
Collapse
|
28
|
Zhao Y, Bai C, Brinker CJ, Chi L, Dawson KA, Gogotsi Y, Halas NJ, Lee ST, Lee T, Liz-Marzán L, Miller JF, Mitra S, Nel AE, Nordlander P, Parak WJ, Rowan A, Rogach AL, Rotello VM, Tang BZ, Wee ATS, Weiss PS. Nano as a Rosetta Stone: The Global Roles and Opportunities for Nanoscience and Nanotechnology. ACS Nano 2019; 13:10853-10855. [PMID: 31683413 DOI: 10.1021/acsnano.9b08042] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
|
29
|
Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol 2019; 14:902. [PMID: 31358944 PMCID: PMC7875076 DOI: 10.1038/s41565-019-0538-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Collapse
Affiliation(s)
- Hon S Leong
- Department of Urology, Mayo Clinic, Rochester, MN, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
| | - Kimberly S Butler
- Department of Nanobiology, Sandia National Laboratories, Albuquerque, NM, USA
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, University of New Mexico Albuquerque, Albuquerque, NM, USA
- Departments of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM, USA
- UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA
| | - May Azzawi
- Cardiovascular Research Group, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
- British Society for Nanomedicine
| | - Steve Conlan
- British Society for Nanomedicine
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Christine Dufès
- British Society for Nanomedicine
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| | - Andrew Owen
- British Society for Nanomedicine
- Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | - Steve Rannard
- British Society for Nanomedicine
- Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, UK
| | - Chris Scott
- British Society for Nanomedicine
- Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK
| | - Chunying Chen
- National Center for Nanoscience and Technology of China, Beijing, China
| | - Marina A Dobrovolskaia
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Serguei V Kozlov
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Adriele Prina-Mello
- Trinity Translational Medicine Institute, Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland
- Laboratory for Biological Characterisation of Advanced Materials, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
- Nanomedicine Group, Advanced Materials and Bioengineering Research (AMBER) centre, Centre for Research on Adaptive Nanostructures and Nanodevices, Trinity College Dublin, Dublin, Ireland
| | | | - Peter Wick
- Empa - Swiss Federal Laboratories for Materials Science and Technology, St Gallen, Switzerland
| | - Fanny Caputo
- University Grenoble Alpes, CEA, LETI, Grenoble, Switzerland
| | | | - Rachael M Crist
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Scott E McNeil
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Lang Tran
- Institute of Occupational Medicine, Edinburgh, UK
| | - Steffen Foss Hansen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Nanna B Hartmann
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lauge P W Clausen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lars M Skjolding
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Anders Baun
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Marlene Ågerstrand
- Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Stockholm, Sweden
| | - Zhen Gu
- Department of Bioengineering, California Nanosystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | | | - Clare Hoskins
- Institute of Science and Technology in Medicine, Keele University, Keele, UK
| | - Leaf Huang
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA
| | - Wantong Song
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - Huiliang Cao
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Xuanyong Liu
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
| | - Klaus D Jandt
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Wen Jiang
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Betty Y S Kim
- Department of Neurosurgery, The University of Texas MD Anderson Cancer, Houston, TX, USA
| | - Korin E Wheeler
- Department of Chemistry and Biochemistry, Santa Clara University, Santa Clara, CA, USA
| | - Andrew J Chetwynd
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Iseult Lynch
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Seyed Moein Moghimi
- School of Pharmacy, Newcastle University, Newcastle upon Tyne, UK
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - André Nel
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Paul S Weiss
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Bruno Sarmento
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - José das Neves
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - Hélder A Santos
- Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
| | - Luis Santos
- Dosage Form Design and Development, MedImmune, LLC, Gaithersburg, MD, USA
| | - Samir Mitragotri
- Wyss Institute of Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
| | - Steve Little
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - Dan Peer
- George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
| | - Mansoor M Amiji
- School of Pharmacy, Northeastern University, Boston, MA, USA
| | - Maria José Alonso
- CIMUS Research Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - Alke Petri-Fink
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Sandor Balog
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Aaron Lee
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Barbara Drasler
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | | | - Stefan Wilhelm
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Handan Acar
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Roger G Harrison
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
- School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK, USA
| | - Chuanbin Mao
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA
- School of Materials Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, China
| | - Priyabrata Mukherjee
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Rajagopal Ramesh
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Lacey R McNally
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Bioengineering, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Sara Busatto
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Joy Wolfram
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
| | - Paolo Bergese
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
- Department of Medicine, Weill Cornell Medicine, Weill Cornell Medicine, New York, NY, USA
| | - Ronnie H Fang
- Department of NanoEngineering, Chemical Engineering Program, University of California, San Diego, La Jolla, CA, USA
| | - Liangfang Zhang
- Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
| | - Jie Zheng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Chuanqi Peng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Bujie Du
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Mengxiao Yu
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Danielle M Charron
- Institute of Biomaterials and Biomedical Engineering, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Gang Zheng
- Department of Medical Biophysics, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | | |
Collapse
|
30
|
Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, Neves JD, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol 2019; 14:811. [PMID: 31289407 DOI: 10.1038/s41565-019-0523-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Collapse
Affiliation(s)
- Hon S Leong
- Department of Urology, Mayo Clinic, Rochester, MN, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
| | - Kimberly S Butler
- Department of Nanobiology, Sandia National Laboratories, Albuquerque, NM, USA
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, University of New Mexico Albuquerque, Albuquerque, NM, USA
- Departments of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM, USA
- UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA
| | - May Azzawi
- Cardiovascular Research Group, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
- British Society for Nanomedicine, Liverpool, UK
| | - Steve Conlan
- British Society for Nanomedicine, Liverpool, UK
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Christine Dufès
- British Society for Nanomedicine, Liverpool, UK
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| | - Andrew Owen
- British Society for Nanomedicine, Liverpool, UK
- Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | - Steve Rannard
- British Society for Nanomedicine, Liverpool, UK
- Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, UK
| | - Chris Scott
- British Society for Nanomedicine, Liverpool, UK
- Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK
| | - Chunying Chen
- National Center for Nanoscience and Technology of China, Beijing, China
| | - Marina A Dobrovolskaia
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Serguei V Kozlov
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Adriele Prina-Mello
- Trinity Translational Medicine Institute, Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland
- Laboratory for Biological Characterisation of Advanced Materials, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
- Nanomedicine Group, Advanced Materials and Bioengineering Research (AMBER) centre, Centre for Research on Adaptive Nanostructures and Nanodevices, Trinity College Dublin, Dublin, Ireland
| | | | - Peter Wick
- Empa -Swiss Federal Laboratories for Materials Science and Technology, St Gallen, Switzerland
| | - Fanny Caputo
- University Grenoble Alpes, CEA, LETI, Grenoble, Switzerland
| | | | - Rachael M Crist
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Scott E McNeil
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Lang Tran
- Institute of Occupational Medicine, Edinburgh, UK
| | - Steffen Foss Hansen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Nanna B Hartmann
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lauge P W Clausen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lars M Skjolding
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Anders Baun
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Marlene Ågerstrand
- Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Stockholm, Sweden
| | - Zhen Gu
- Department of Bioengineering, California Nanosystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | | | - Clare Hoskins
- Institute of Science and Technology in Medicine, Keele University, Keele, UK
| | - Leaf Huang
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA
| | - Wantong Song
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - Huiliang Cao
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Xuanyong Liu
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
| | - Klaus D Jandt
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Wen Jiang
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Betty Y S Kim
- Department of Neurosurgery, The University of Texas MD Anderson Cancer, Houston, TX, USA
| | - Korin E Wheeler
- Department of Chemistry and Biochemistry, Santa Clara University, Santa Clara, CA, USA
| | - Andrew J Chetwynd
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Iseult Lynch
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Sayed Moein Moghimi
- School of Pharmacy, Newcastle University, Newcastle upon Tyne, UK
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - André Nel
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Paul S Weiss
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Bruno Sarmento
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - José das Neves
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - Hélder A Santos
- Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
| | - Luis Santos
- Dosage Form Design and Development, MedImmune, LLC, Gaithersburg, MD, USA
| | - Samir Mitragotri
- Wyss Institute of Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
| | - Steve Little
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - Dan Peer
- George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
| | - Mansoor M Amiji
- School of Pharmacy, Northeastern University, Boston, MA, USA
| | - Maria José Alonso
- CIMUS Research Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - Alke Petri-Fink
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Sandor Balog
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Aaron Lee
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Barbara Drasler
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | | | - Stefan Wilhelm
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Handan Acar
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Roger G Harrison
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
- School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK, USA
| | - Chuanbin Mao
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA
- School of Materials Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, China
| | - Priyabrata Mukherjee
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Rajagopal Ramesh
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Lacey R McNally
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Bioengineering, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Sara Busatto
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Joy Wolfram
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
| | - Paolo Bergese
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
- Department of Medicine, Weill Cornell Medicine, Weill Cornell Medicine, New York, NY, USA
| | - Ronnie H Fang
- Department of NanoEngineering, Chemical Engineering Program, University of California, San Diego, La Jolla, CA, USA
| | - Liangfang Zhang
- Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
| | - Jie Zheng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Chuanqi Peng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Bujie Du
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Mengxiao Yu
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Danielle M Charron
- Institute of Biomaterials and Biomedical Engineering, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Gang Zheng
- Department of Medical Biophysics, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | | |
Collapse
|
31
|
Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C. On the issue of transparency and reproducibility in nanomedicine. Nat Nanotechnol 2019; 14:629-635. [PMID: 31270452 PMCID: PMC6939883 DOI: 10.1038/s41565-019-0496-9] [Citation(s) in RCA: 112] [Impact Index Per Article: 22.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Affiliation(s)
- Hon S Leong
- Department of Urology, Mayo Clinic, Rochester, MN, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA
| | - Kimberly S Butler
- Department of Nanobiology, Sandia National Laboratories, Albuquerque, NM, USA
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, University of New Mexico Albuquerque, Albuquerque, NM, USA
- Departments of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM, USA
- UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USA
| | - May Azzawi
- Cardiovascular Research Group, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
- British Society for Nanomedicine
| | - Steve Conlan
- British Society for Nanomedicine
- Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK
| | - Christine Dufés
- British Society for Nanomedicine
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
| | - Andrew Owen
- British Society for Nanomedicine
- Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
| | - Steve Rannard
- British Society for Nanomedicine
- Department of Chemistry, School of Physical Sciences, University of Liverpool, Liverpool, UK
| | - Chris Scott
- British Society for Nanomedicine
- Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK
| | - Chunying Chen
- National Center for Nanoscience and Technology of China, Beijing, China
| | - Marina A Dobrovolskaia
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Serguei V Kozlov
- Laboratory of Animal Sciences Program, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Adriele Prina-Mello
- Trinity Translational Medicine Institute, Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland
- Laboratory for Biological Characterisation of Advanced Materials, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
- Nanomedicine Group, Advanced Materials and Bioengineering Research (AMBER) centre, Centre for Research on Adaptive Nanostructures and Nanodevices, Trinity College Dublin, Dublin, Ireland
| | | | - Peter Wick
- Empa - Swiss Federal Laboratories for Materials Science and Technology, St Gallen, Switzerland
| | - Fanny Caputo
- University Grenoble Alpes, CEA, LETI, Grenoble, Switzerland
| | | | - Rachael M Crist
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Scott E McNeil
- Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Lang Tran
- Institute of Occupational Medicine, Edinburgh, UK
| | - Steffen Foss Hansen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Nanna B Hartmann
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lauge P W Clausen
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Lars M Skjolding
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Anders Baun
- Department of Environmental Engineering, Technical University of Denmark, Kongens Lyngby, Denmark
| | - Marlene Ågerstrand
- Department of Environmental Science and Analytical Chemistry (ACES), Stockholm University, Stockholm, Sweden
| | - Zhen Gu
- Department of Bioengineering, California Nanosystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | | | - Clare Hoskins
- Institute of Science and Technology in Medicine, Keele University, Keele, UK
| | - Leaf Huang
- Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA
| | - Wantong Song
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China
| | - Huiliang Cao
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Xuanyong Liu
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, China
| | - Klaus D Jandt
- Otto Schott Institute of Materials Research, Friedrich Schiller University Jena, Jena, Germany
| | - Wen Jiang
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Betty Y S Kim
- Department of Neurosurgery, The University of Texas MD Anderson Cancer, Houston, TX, USA
| | - Korin E Wheeler
- Department of Chemistry and Biochemistry, Santa Clara University, Santa Clara, CA, USA
| | - Andrew J Chetwynd
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Iseult Lynch
- School of Geography Earth and Environmental Sciences, University of Birmingham, Birmingham, UK
| | - Seyed Moein Moghimi
- School of Pharmacy, Newcastle University, Newcastle upon Tyne, UK
- Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - André Nel
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Paul S Weiss
- Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA
- Department of Materials Science and Engineering, California NanoSystems Institute, University of California, Los Angeles, Los Angeles, CA, USA
| | - Bruno Sarmento
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - José das Neves
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal
| | - Hélder A Santos
- Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
| | - Luis Santos
- Dosage Form Design and Development, MedImmune, LLC, Gaithersburg, MD, USA
| | - Samir Mitragotri
- Wyss Institute of Biologically Inspired Engineering, Harvard University, Cambridge, MA, USA
| | - Steve Little
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA
| | - Dan Peer
- George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
| | - Mansoor M Amiji
- School of Pharmacy, Northeastern University, Boston, MA, USA
| | - Maria José Alonso
- CIMUS Research Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | - Alke Petri-Fink
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Sandor Balog
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Aaron Lee
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | - Barbara Drasler
- Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland
| | | | - Stefan Wilhelm
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Handan Acar
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
| | - Roger G Harrison
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA
- Stephenson Cancer Center, Oklahoma City, OK, USA
- School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK, USA
| | - Chuanbin Mao
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA
- School of Materials Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, China
| | - Priyabrata Mukherjee
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Rajagopal Ramesh
- Stephenson Cancer Center, Oklahoma City, OK, USA
- Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Lacey R McNally
- Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- Department of Bioengineering, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | - Sara Busatto
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Joy Wolfram
- Department of Transplantation Medicine, Mayo Clinic, Jacksonville, FL, USA
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
| | - Paolo Bergese
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
- CSGI, Research Center for Colloids and Nanoscience, Florence, Italy
| | - Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA
- Department of Medicine, Weill Cornell Medicine, Weill Cornell Medicine, New York, NY, USA
| | - Ronnie H Fang
- Department of NanoEngineering, Chemical Engineering Program, University of California, San Diego, La Jolla, CA, USA
| | - Liangfang Zhang
- Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
| | - Jie Zheng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Chuanqi Peng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Bujie Du
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Mengxiao Yu
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, Richardson, TX, USA
| | - Danielle M Charron
- Institute of Biomaterials and Biomedical Engineering, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Gang Zheng
- Department of Medical Biophysics, University of Toronto Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | | |
Collapse
|
32
|
Zhu W, Guo J, Amini S, Ju Y, Agola JO, Zimpel A, Shang J, Noureddine A, Caruso F, Wuttke S, Croissant JG, Brinker CJ. SupraCells: Living Mammalian Cells Protected within Functional Modular Nanoparticle-Based Exoskeletons. Adv Mater 2019; 31:e1900545. [PMID: 31032545 DOI: 10.1002/adma.201900545] [Citation(s) in RCA: 80] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Revised: 03/31/2019] [Indexed: 06/09/2023]
Abstract
Creating a synthetic exoskeleton from abiotic materials to protect delicate mammalian cells and impart them with new functionalities could revolutionize fields like cell-based sensing and create diverse new cellular phenotypes. Herein, the concept of "SupraCells," which are living mammalian cells encapsulated and protected within functional modular nanoparticle-based exoskeletons, is introduced. Exoskeletons are generated within seconds through immediate interparticle and cell/particle complexation that abolishes the macropinocytotic and endocytotic nanoparticle internalization pathways that occur without complexation. SupraCell formation is shown to be generalizable to wide classes of nanoparticles and various types of cells. It induces a spore-like state, wherein cells do not replicate or spread on surfaces but are endowed with extremophile properties, for example, resistance to osmotic stress, reactive oxygen species, pH, and UV exposure, along with abiotic properties like magnetism, conductivity, and multifluorescence. Upon decomplexation cells return to their normal replicative states. SupraCells represent a new class of living hybrid materials with a broad range of functionalities.
Collapse
Affiliation(s)
- Wei Zhu
- School of Biology and Biological Engineering, South China University of Technology, 382 East Outer Loop Road, University Park, Guangzhou, 510006, P. R. China
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Shahrouz Amini
- Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, 14476, Potsdam, Germany
| | - Yi Ju
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Jacob Ongudi Agola
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Andreas Zimpel
- Department of Chemistry and Center for NanoScience (CeNS), University of Munich (LMU), Butenandtstraße 11, 81377, Munich, Germany
| | - Jin Shang
- School of Energy and Environment, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR, P. R. China
| | - Achraf Noureddine
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Stefan Wuttke
- Department of Chemistry and Center for NanoScience (CeNS), University of Munich (LMU), Butenandtstraße 11, 81377, Munich, Germany
| | - Jonas G Croissant
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| |
Collapse
|
33
|
Zhu W, Guo J, Agola JO, Croissant JG, Wang Z, Shang J, Coker E, Motevalli B, Zimpel A, Wuttke S, Brinker CJ. Metal–Organic Framework Nanoparticle-Assisted Cryopreservation of Red Blood Cells. J Am Chem Soc 2019; 141:7789-7796. [DOI: 10.1021/jacs.9b00992] [Citation(s) in RCA: 59] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Wei Zhu
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jimin Guo
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jacob Ongudi Agola
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jonas G. Croissant
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Zihao Wang
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Jin Shang
- School of Energy and Environment, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR, P.R. China
| | - Eric Coker
- Applied Optical/Plasma Sciences, Sandia National Laboratories, P.O. Box 5800,
MS 1411, Albuquerque, New Mexico 87185-1411, United States
| | - Benyamin Motevalli
- Department of Mechanical and Aerospace Engineering, Monash University, Clayton, Victoria 3800, Australia
| | - Andreas Zimpel
- Department of Chemistry and Center for NanoScience (CeNS), University of Munich (LMU), 81377 Munich, Germany
| | - Stefan Wuttke
- Department of Chemistry and Center for NanoScience (CeNS), University of Munich (LMU), 81377 Munich, Germany
- School of Chemistry, Joseph Banks Laboratories, University of Lincoln, Lincoln LN6 7TS, United Kingdom
| | - C. Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, New Mexico 87131, United States
| |
Collapse
|
34
|
Zhu W, Noureddine A, Howe JY, Guo J, Brinker CJ. Conversion of Metal-Organic Cage to Ligand-Free Ultrasmall Noble Metal Nanocluster Catalysts Confined within Mesoporous Silica Nanoparticle Supports. Nano Lett 2019; 19:1512-1519. [PMID: 30716276 DOI: 10.1021/acs.nanolett.8b04121] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Supported ultrasmall noble metal nanocluster-based (UNMN-based) catalysts are one of the most important classes of solid materials for heterogeneous catalysis. In this work, we present a novel strategy for the controlled synthesis of ligand-free UNMN nanocatalysts based on in situ reduction of a palladium-based (Pd-based) metal-organic cage (MOC) confined within monosized, thiol-modified mesoporous silica nanoparticle (MSN) supports. By taking advantage of the high mutual solubility of MOCs and MSNs in DMSO and the strong interactions between the thiol-modified MSN pore wall and MOC surface, a good dispersion of MOC molecules was achieved throughout the MSN support. The close correspondence of the MSN pore diameter (ca. 5.0 nm) with the diameter of the MOC (ca. 4.0 nm) confines MOC packing to approximately a monolayer. Based on this spatial constraint and electrostatic binding of the MOC to the thiol-modified MSN pore surface, in situ MOC reduction followed by metal atom diffusion, coalescence, and anchoring on the active sites resulted in ligand-free Pd-based UNMNs of approximately 0.9 ± 0.2 nm in diameter decorating the MSN pore surfaces. Control experiments of the reduction of a conventional palladium source or the reduction of free, unconstrained cages in solution under the same conditions only produced large metal nanocrystals (NP, >2 nm), confirming the importance of confined reduction to achieve a highly catalytically active surface. In light of this strategy, two catalytic experiments including the reaction of 4-nitrophenol to 4-aminophenol and the Suzuki C-C coupling reaction show superior catalytic activity of the engineered MSN-supported UNMN nanocatalysts compared to their free form and state of the art commercial catalysts. We believe that our new strategy will open new avenues for artificially designed UNMN-inspired nanoarchitectures for wide applications.
Collapse
Affiliation(s)
- Wei Zhu
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering , The University of New Mexico , Albuquerque , New Mexico 87131 , United States
| | - Achraf Noureddine
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering , The University of New Mexico , Albuquerque , New Mexico 87131 , United States
| | - Jane Y Howe
- Nanotechnology Systems Division , Hitachi High-Technologies America Inc. , 22610 Gateway Center Drive #100 , Clarksburg , Maryland 20871 , United States
| | - Jimin Guo
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering , The University of New Mexico , Albuquerque , New Mexico 87131 , United States
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials and the Department of Chemical and Biological Engineering , The University of New Mexico , Albuquerque , New Mexico 87131 , United States
- Advanced Materials Laboratory , Sandia National Laboratories , Albuquerque , New Mexico 87185 , United States
| |
Collapse
|
35
|
Brocato TA, Brown-Glaberman U, Wang Z, Selwyn RG, Wilson CM, Wyckoff EF, Lomo LC, Saline JL, Hooda-Nehra A, Pasqualini R, Arap W, Brinker CJ, Cristini V. Predicting breast cancer response to neoadjuvant chemotherapy based on tumor vascular features in needle biopsies. JCI Insight 2019; 5:126518. [PMID: 30835256 DOI: 10.1172/jci.insight.126518] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
In clinical breast cancer intervention, selection of the optimal treatment protocol based on predictive biomarkers remains an elusive goal. Here, we present a modeling tool to predict the likelihood of breast cancer response to neoadjuvant chemotherapy using patient specific tumor vasculature biomarkers. A semi-automated analysis was implemented and performed on 3990 histological images from 48 patients, with 10-208 images analyzed for each patient. We applied a histology-based model to resected primary breast cancer tumors (n = 30), and then evaluated a cohort of patients (n = 18) undergoing neoadjuvant chemotherapy, collecting pre- and post-treatment pathology specimens and MRI data. We found that core biopsy samples can be used with acceptable accuracy (r = 0.76) to determine histological parameters representative of the whole tissue region. Analysis of model histology parameters obtained from tumor vasculature measurements, specifically diffusion distance divided by radius of drug source (L/rb) and blood volume fraction (BVF), provides a statistically significant separation of patients obtaining a pathologic complete response (pCR) from those that do not (Student's t-test; P < 0.05). With this model, it is feasible to evaluate primary breast tumor vasculature biomarkers in a patient specific manner, thereby allowing a precision approach to breast cancer treatment.
Collapse
Affiliation(s)
- Terisse A Brocato
- Department of Chemical and Biological Engineering and Center for Biomedical Engineering, University of New Mexico, Albuquerque, New Mexico, USA
| | - Ursa Brown-Glaberman
- University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, USA
| | - Zhihui Wang
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA.,Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Reed G Selwyn
- Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.,Department of Radiology, University of New Mexico, Albuquerque, New Mexico, USA
| | - Colin M Wilson
- Department of Radiology, University of New Mexico, Albuquerque, New Mexico, USA
| | - Edward F Wyckoff
- Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, New Mexico, USA
| | - Lesley C Lomo
- Department of Pathology, University of Utah, Salt Lake City, Utah, USA
| | - Jennifer L Saline
- Department of Radiology, University of New Mexico, Albuquerque, New Mexico, USA
| | - Anupama Hooda-Nehra
- Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.,Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA
| | - Renata Pasqualini
- Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.,Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA
| | - Wadih Arap
- Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.,Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA
| | - C Jeffrey Brinker
- Department of Chemical and Biological Engineering and Center for Biomedical Engineering, University of New Mexico, Albuquerque, New Mexico, USA.,Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, New Mexico, USA.,Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA.,Self-Assembled Materials Department, Sandia National Laboratories, Albuquerque, New Mexico, USA
| | - Vittorio Cristini
- Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA.,Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.,Department of Nanomedicine, Methodist Hospital Research Institute, Houston, Texas, USA
| |
Collapse
|
36
|
Zhu W, Guo J, Ju Y, Serda RE, Croissant JG, Shang J, Coker E, Agola JO, Zhong QZ, Ping Y, Caruso F, Brinker CJ. Modular Metal-Organic Polyhedra Superassembly: From Molecular-Level Design to Targeted Drug Delivery. Adv Mater 2019; 31:e1806774. [PMID: 30702780 PMCID: PMC7482105 DOI: 10.1002/adma.201806774] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Revised: 01/13/2019] [Indexed: 05/10/2023]
Abstract
Targeted drug delivery remains at the forefront of biomedical research but remains a challenge to date. Herein, the first superassembly of nanosized metal-organic polyhedra (MOP) and their biomimetic coatings of lipid bilayers are described to synergistically combine the advantages of micelles and supramolecular coordination cages for targeted drug delivery. The superassembly technique affords unique hydrophobic features that endow individual MOP to act as nanobuilding blocks and enable their superassembly into larger and well-defined nanocarriers with homogeneous sizes over a broad range of diameters. Various cargos are controllably loaded into the MOP with high payloads, and the nanocages are then superassembled to form multidrug delivery systems. Additionally, functional nanoparticles are introduced into the superassemblies via a one-pot process for versatile bioapplications. The MOP superassemblies are surface-engineered with epidermal growth factor receptors and can be targeted to cancer cells. In vivo studies indicated the assemblies to have a substantial circulation half-life of 5.6 h and to undergo renal clearance-characteristics needed for nanomedicines.
Collapse
Affiliation(s)
- Wei Zhu
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Jimin Guo
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Yi Ju
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Rita E Serda
- Department of Internal Medicine, Molecular Medicine, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Jonas G Croissant
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Jin Shang
- School of Energy and Environment, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong SAR, P. R. China
| | - Eric Coker
- Sandia National Laboratories, Applied Optical/Plasma Sciences, P.O. Box 5800, MS 1411, Albuquerque, NM, 87185-1411, USA
| | - Jacob Ongudi Agola
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| | - Qi-Zhi Zhong
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Yuan Ping
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and The Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM, 87131, USA
| |
Collapse
|
37
|
Abstract
Silica-based nanomaterials are extensively used in industrial applications and academic biomedical research, thus properly assessing their toxicity and biodegradability is essential for their safe and effective formulation and use. Unfortunately, there is often a lot of confusion in the literature with respect to the toxicity and biodegradability of silica since various studies have yielded contradictory results. In this contribution, we first endeavor to underscore that the simplistic model of silica should be discarded in favor of a more realistic model recognizing that all silicas are not created equal and should thus be considered in the plural as silicas and silica hybrids, which indeed hold various biocompatibility and biodegradability profiles. We then demonstrated that all silicas are-as displayed in Nature-degradable in water by dissolution, as governed by the laws of kinetics. Lastly, we explore the vast potential of tuning the degradability of silica by materials design using various silica hybrids for redox-, pH-, enzymatic-, and biochelation-mediated lysis mechanisms.
Collapse
Affiliation(s)
- Jonas G Croissant
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States; Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico, Albuquerque, NM, United States.
| | - C Jeffrey Brinker
- Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, United States; Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico, Albuquerque, NM, United States
| |
Collapse
|
38
|
Gonzalez Porras MA, Durfee P, Giambini S, Sieck GC, Brinker CJ, Mantilla CB. Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons. Nanomedicine 2018; 14:661-672. [PMID: 29339186 DOI: 10.1016/j.nano.2018.01.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2017] [Revised: 11/30/2017] [Accepted: 01/02/2018] [Indexed: 02/02/2023]
Abstract
Cholera toxin B (CTB) modified mesoporous silica nanoparticle supported lipid bilayers (CTB-protocells) are a promising, customizable approach for targeting therapeutic cargo to motoneurons. In the present study, the endocytic mechanism and intracellular fate of CTB-protocells in motoneurons were examined to provide information for the development of therapeutic application and cargo delivery. Pharmacological inhibitors elucidated CTB-protocells endocytosis to be dependent on the integrity of lipid rafts and macropinocytosis. Using immunofluorescence techniques, live confocal and transmission electron microscopy, CTB-protocells were primarily found in the cytosol, membrane lipid domains and Golgi. There was no difference in the amount of motoneuron activity dependent uptake of CTB-protocells in neuromuscular junctions, consistent with clathrin activation at the axon terminals during low frequency activity. In conclusion, CTB-protocells uptake is mediated principally by lipid rafts and macropinocytosis. Once internalized, CTB-protocells escape lysosomal degradation, and engage biological pathways that are not readily accessible by untargeted delivery methods.
Collapse
Affiliation(s)
- Maria A Gonzalez Porras
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States
| | - Paul Durfee
- Center for Micro-Engineered Materials, University of New, Mexico
| | - Sebastian Giambini
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States
| | - Gary C Sieck
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States
| | - C Jeffrey Brinker
- Center for Micro-Engineered Materials, University of New, Mexico; Department of Chemical and Biological Engineering University of New, Mexico; Department of Molecular Genetics and Microbiology University of New, Mexico; Self-Assembled Materials Department, Sandia National Laboratories, Albuquerque, New, Mexico
| | - Carlos B Mantilla
- Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, United States; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, United States.
| |
Collapse
|
39
|
Brett SI, Lucien F, Guo C, Williams KC, Kim Y, Durfee PN, Brinker CJ, Chin JI, Yang J, Leong HS. Immunoaffinity based methods are superior to kits for purification of prostate derived extracellular vesicles from plasma samples. Prostate 2017; 77:1335-1343. [PMID: 28762517 DOI: 10.1002/pros.23393] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2017] [Accepted: 07/03/2017] [Indexed: 01/09/2023]
Abstract
BACKGROUND The ability to isolate extracellular vesicles (EVs) such as exosomes or microparticles is an important method that is currently not standardized. While commercially available kits offer purification of EVs from biofluids, such purified EV samples will also contain non-EV entities such as soluble protein and nucleic acids that could confound subsequent experimentation. Ideally, only EVs would be isolated and no soluble protein would be present in the final EV preparation. METHODS We compared commercially available EV isolation kits with immunoaffinity purification techniques and evaluated our final EV preparations using atomic force microscopy (AFM) and nanoscale flow cytometry (NFC). AFM is the only modality capable of detecting distinguishing soluble protein from EVs which is important for downstream proteomics approaches. NFC is the only technique capable of quantitating the proportion of target EVs to non-target EVs in the final EV preparation. RESULTS To determine enrichment of prostate derived EVs relative to non-target MPs, anti-PSMA (Prostate Specific Membrane Antigen) antibodies were used in NFC. Antibody-based immunoaffinity purification generated the highest quality of prostate derived EV preparations due to the lack of protein and RNA present in the samples. All kits produced poor purity EV preparations that failed to deplete the sample of plasma protein. CONCLUSIONS While attractive due to their ease of use, EV purification kits do not provide substantial improvements in isolation of EVs from biofluids such as plasma. Immunoaffinity approaches are more efficient and economical and will also eliminate a significant portion of plasma proteins which is necessary for downstream approaches.
Collapse
Affiliation(s)
- Sabine I Brett
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
| | - Fabrice Lucien
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
- Department of Urology, Mayo Clinic, Rochester, Minnesota
| | - Charles Guo
- Department of Mechanical and Materials Engineering, Western University, London, Ontario
| | - Karla C Williams
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
| | - Yohan Kim
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
- Department of Urology, Mayo Clinic, Rochester, Minnesota
| | - Paul N Durfee
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico
| | - C J Brinker
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, New Mexico
- Sandia National Laboratories, Albuquerque, New Mexico
| | - Joseph I Chin
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
| | - Jun Yang
- Department of Mechanical and Materials Engineering, Western University, London, Ontario
| | - Hon S Leong
- Translational Prostate Cancer Research Laboratory, Lawson Health Research Institute, London, Ontario
- Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, Ontario
- Department of Urology, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
40
|
Wang H, Zhu W, Ping Y, Wang C, Gao N, Yin X, Gu C, Ding D, Brinker CJ, Li G. Controlled Fabrication of Functional Capsules Based on the Synergistic Interaction between Polyphenols and MOFs under Weak Basic Condition. ACS Appl Mater Interfaces 2017; 9:14258-14264. [PMID: 28398036 DOI: 10.1021/acsami.7b01788] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Metal-organic coordination materials with controllable nanostructures are of widespread interest due to the coupled benefits of inorganic/organic building blocks and desired architectures. In this work, based on the finding of a synergistic interaction between metal-organic frameworks (MOFs) and natural polyphenols under weak basic condition, a facile strategy has been developed for directly fabricating diverse phenolic-inspired functional materials or metal-phenolic frameworks (MPFs) with controlled hollow nanostructures (polyhedral core-shell, rattle-like, hollow cage, etc.) and controllable size, morphology, and roughness, as well as composition. By further incorporating the diverse functionalities of polyphenols such as low toxicity and therapeutic properties, catalytic activity, and ability to serve as carbon precursors, into the novel assemblies, diverse artificially designed nanoarchitectures with target functionalities have been generated for an array of applications.
Collapse
Affiliation(s)
- Hui Wang
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
- College of Chemical Engineering, Shijiazhuang University , Shijiazhuang 050035, P. R. China
| | - Wei Zhu
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
- Advanced Materials Laboratory, Sandia National Laboratories , Albuquerque, New Mexico 87185, United States
| | - Yuan Ping
- School of Materials Science and Engineering, Nanyang Technological University , Singapore 639798, Singapore
- School of Pharmaceutical Sciences, Higher Education Mega Center, Sun Yat-Sen University , Panyu, Guangzhou 510006, China
| | - Chen Wang
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
| | - Ning Gao
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
| | - Xianpeng Yin
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
| | - Chen Gu
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
| | - Dan Ding
- State Key Laboratory of Medicinal Chemical Biology, Nankai University , Tianjin 300071, People's Republic of China
| | - C Jeffrey Brinker
- Advanced Materials Laboratory, Sandia National Laboratories , Albuquerque, New Mexico 87185, United States
| | - Guangtao Li
- Key Lab of Organic Optoelectronic and Molecular Engineering, Department of Chemistry, Tsinghua University , Beijing 10084, People's Republic of China
| |
Collapse
|
41
|
Fazal Z, Pelowitz J, Johnson PE, Harper JC, Brinker CJ, Jakobsson E. Three-Dimensional Encapsulation of Saccharomyces cerevisiae in Silicate Matrices Creates Distinct Metabolic States as Revealed by Gene Chip Analysis. ACS Nano 2017; 11:3560-3575. [PMID: 28287261 DOI: 10.1021/acsnano.6b06385] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
In order to design hybrid cellular/synthetic devices such as sensors and vaccines, it is important to understand how the metabolic state of living cells changes upon physical confinement within three-dimensional (3D) matrices. We analyze the gene expression patterns of stationary phase Saccharomyces cerevisiae (S. cerevisiae) cells encapsulated within three distinct nanostructured silica matrices and relate those patterns to known naturally occurring metabolic states. Silica encapsulation methods employed were lipid-templated mesophase silica thin films formed by cell-directed assembly (CDA), lipid-templated mesophase silica particles formed by spray drying (SD), and glycerol-doped silica gel monoliths prepared from an aqueous silicate (AqS+g) precursor solution. It was found that the cells for all three-encapsulated methods enter quiescent states characteristic of response to stress, albeit to different degrees and with differences in detail. By the measure of enrichment of stress-related gene ontology categories, we find that the AqS+g encapsulation is more amenable to the cells than CDA and SD encapsulation. We hypothesize that this differential response in the AqS+g encapsulation is related to four properties of the encapsulating gel: (1) oxygen permeability, (2) relative softness of the material, (3) development of a protective sheath around individual cells (visible in TEM micrographs vide infra), and (4) the presence of glycerol in the gel, which has been previously noted to serve as a protectant for encapsulated cells and can serve as the sole carbon source for S. cerevisiae under aerobic conditions. This work represents a combination of experiment and analysis aimed at the design and development of 3D encapsulation procedures to induce, and perhaps control, well-defined physiological behaviors.
Collapse
Affiliation(s)
- Zeeshan Fazal
- Department of Biosciences, COMSATS Institute of Information Technology , Park Road, Tarlai Kalan, Islamabad 45550, Pakistan
| | | | | | | | | | | |
Collapse
|
42
|
Yao VJ, D'Angelo S, Butler KS, Theron C, Smith TL, Marchiò S, Gelovani JG, Sidman RL, Dobroff AS, Brinker CJ, Bradbury ARM, Arap W, Pasqualini R. Ligand-targeted theranostic nanomedicines against cancer. J Control Release 2016; 240:267-286. [PMID: 26772878 PMCID: PMC5444905 DOI: 10.1016/j.jconrel.2016.01.002] [Citation(s) in RCA: 125] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2015] [Revised: 12/17/2015] [Accepted: 01/02/2016] [Indexed: 02/06/2023]
Abstract
Nanomedicines have significant potential for cancer treatment. Although the majority of nanomedicines currently tested in clinical trials utilize simple, biocompatible liposome-based nanocarriers, their widespread use is limited by non-specificity and low target site concentration and thus, do not provide a substantial clinical advantage over conventional, systemic chemotherapy. In the past 20years, we have identified specific receptors expressed on the surfaces of tumor endothelial and perivascular cells, tumor cells, the extracellular matrix and stromal cells using combinatorial peptide libraries displayed on bacteriophage. These studies corroborate the notion that unique receptor proteins such as IL-11Rα, GRP78, EphA5, among others, are differentially overexpressed in tumors and present opportunities to deliver tumor-specific therapeutic drugs. By using peptides that bind to tumor-specific cell-surface receptors, therapeutic agents such as apoptotic peptides, suicide genes, imaging dyes or chemotherapeutics can be precisely and systemically delivered to reduce tumor growth in vivo, without harming healthy cells. Given the clinical applicability of peptide-based therapeutics, targeted delivery of nanocarriers loaded with therapeutic cargos seems plausible. We propose a modular design of a functionalized protocell in which a tumor-targeting moiety, such as a peptide or recombinant human antibody single chain variable fragment (scFv), is conjugated to a lipid bilayer surrounding a silica-based nanocarrier core containing a protected therapeutic cargo. The functionalized protocell can be tailored to a specific cancer subtype and treatment regimen by exchanging the tumor-targeting moiety and/or therapeutic cargo or used in combination to create unique, theranostic agents. In this review, we summarize the identification of tumor-specific receptors through combinatorial phage display technology and the use of antibody display selection to identify recombinant human scFvs against these tumor-specific receptors. We compare the characteristics of different types of simple and complex nanocarriers, and discuss potential types of therapeutic cargos and conjugation strategies. The modular design of functionalized protocells may improve the efficacy and safety of nanomedicines for future cancer therapy.
Collapse
Affiliation(s)
- Virginia J Yao
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131
| | - Sara D'Angelo
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131
| | - Kimberly S Butler
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131
| | - Christophe Theron
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131
| | - Tracey L Smith
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131
| | - Serena Marchiò
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131; Department of Oncology, University of Turin, Candiolo, 10060, Italy
| | - Juri G Gelovani
- Department of Biomedical Engineering, College of Engineering and School of Medicine, Wayne State University, Detroit, MI 48201
| | - Richard L Sidman
- Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215
| | - Andrey S Dobroff
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131
| | - C Jeffrey Brinker
- Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131; Center for Micro-Engineered Materials, University of New Mexico, Albuquerque, NM 87131; Cancer Research and Treatment Center, Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, NM 87131; Self-Assembled Materials Department, Sandia National Laboratories, Albuquerque, NM 87185
| | - Andrew R M Bradbury
- Bioscience Division, Los Alamos National Laboratories, Los Alamos, NM, 87545
| | - Wadih Arap
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Hematology/Oncology, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131.
| | - Renata Pasqualini
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87131; Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131.
| |
Collapse
|
43
|
Durfee PN, Lin YS, Dunphy DR, Muñiz AJ, Butler KS, Humphrey KR, Lokke AJ, Agola JO, Chou SS, Chen IM, Wharton W, Townson JL, Willman CL, Brinker CJ. Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells. ACS Nano 2016; 10:8325-45. [PMID: 27419663 DOI: 10.1021/acsnano.6b02819] [Citation(s) in RCA: 137] [Impact Index Per Article: 17.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Many nanocarrier cancer therapeutics currently under development, as well as those used in the clinical setting, rely upon the enhanced permeability and retention (EPR) effect to passively accumulate in the tumor microenvironment and kill cancer cells. In leukemia, where leukemogenic stem cells and their progeny circulate within the peripheral blood or bone marrow, the EPR effect may not be operative. Thus, for leukemia therapeutics, it is essential to target and bind individual circulating cells. Here, we investigate mesoporous silica nanoparticle (MSN)-supported lipid bilayers (protocells), an emerging class of nanocarriers, and establish the synthesis conditions and lipid bilayer composition needed to achieve highly monodisperse protocells that remain stable in complex media as assessed in vitro by dynamic light scattering and cryo-electron microscopy and ex ovo by direct imaging within a chick chorioallantoic membrane (CAM) model. We show that for vesicle fusion conditions where the lipid surface area exceeds the external surface area of the MSN and the ionic strength exceeds 20 mM, we form monosized protocells (polydispersity index <0.1) on MSN cores with varying size, shape, and pore size, whose conformal zwitterionic supported lipid bilayer confers excellent stability as judged by circulation in the CAM and minimal opsonization in vivo in a mouse model. Having established protocell formulations that are stable colloids, we further modified them with anti-EGFR antibodies as targeting agents and reverified their monodispersity and stability. Then, using intravital imaging in the CAM, we directly observed in real time the progression of selective targeting of individual leukemia cells (using the established REH leukemia cell line transduced with EGFR) and delivery of a model cargo. Overall, we have established the effectiveness of the protocell platform for individual cell targeting and delivery needed for leukemia and other disseminated disease.
Collapse
Affiliation(s)
- Paul N Durfee
- Chemical and Biological Engineering, University of New Mexico , 210 University Blvd NE, Albuquerque, New Mexico 87131-0001, United States
- Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico , MSC04 2790, 1001 University Blvd SE, Suite 103, Albuquerque, New Mexico 87106, United States
| | - Yu-Shen Lin
- Internal Medicine, University of New Mexico , MSC10 5550, 1 University of New Mexico, Albuquerque, New Mexico 87131, United States
- Oncothyreon, Inc. , 2601 Fourth Avenue, Seattle, Washington 98121-3222, United States
| | - Darren R Dunphy
- Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico , MSC04 2790, 1001 University Blvd SE, Suite 103, Albuquerque, New Mexico 87106, United States
| | - Ayşe J Muñiz
- Health Sciences Center, Biochemistry and Molecular Biology, University of New Mexico , MSC08 4670, 1 University of New Mexico, Albuquerque, New Mexico 87131-5001, United States
| | - Kimberly S Butler
- Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico , MSC04 2790, 1001 University Blvd SE, Suite 103, Albuquerque, New Mexico 87106, United States
| | - Kevin R Humphrey
- Biomedical Engineering, Vanderbilt University , 2301 Vanderbilt Place, Nashville, Tennessee 37235-1826, United States
| | - Amanda J Lokke
- Health Sciences Center, Biochemistry and Molecular Biology, University of New Mexico , MSC08 4670, 1 University of New Mexico, Albuquerque, New Mexico 87131-5001, United States
| | - Jacob O Agola
- Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico , MSC04 2790, 1001 University Blvd SE, Suite 103, Albuquerque, New Mexico 87106, United States
| | - Stanley S Chou
- Advanced Materials Laboratory, Sandia National Laboratories , 1001 University Blvd. SE, Suite 100, Albuquerque, New Mexico 87106, United States
| | - I-Ming Chen
- Department of Pathology, University of New Mexico , MSC08 4640, 1 University of New Mexico, Albuquerque, New Mexico 87131-0001, United States
- Comprehensive Cancer Center, The University of New Mexico , MSC07 4025, 1 University of New Mexico, 1201 Camino de Salud NE, Albuquerque, New Mexico 87131-0001, United States
| | - Walker Wharton
- Department of Pathology, University of New Mexico , MSC08 4640, 1 University of New Mexico, Albuquerque, New Mexico 87131-0001, United States
- Comprehensive Cancer Center, The University of New Mexico , MSC07 4025, 1 University of New Mexico, 1201 Camino de Salud NE, Albuquerque, New Mexico 87131-0001, United States
| | - Jason L Townson
- Internal Medicine, University of New Mexico , MSC10 5550, 1 University of New Mexico, Albuquerque, New Mexico 87131, United States
- Oncothyreon, Inc. , 2601 Fourth Avenue, Seattle, Washington 98121-3222, United States
| | - Cheryl L Willman
- Department of Pathology, University of New Mexico , MSC08 4640, 1 University of New Mexico, Albuquerque, New Mexico 87131-0001, United States
- Comprehensive Cancer Center, The University of New Mexico , MSC07 4025, 1 University of New Mexico, 1201 Camino de Salud NE, Albuquerque, New Mexico 87131-0001, United States
| | - C Jeffrey Brinker
- Chemical and Biological Engineering, University of New Mexico , 210 University Blvd NE, Albuquerque, New Mexico 87131-0001, United States
- Center for Micro-Engineered Materials, Advanced Materials Laboratory, University of New Mexico , MSC04 2790, 1001 University Blvd SE, Suite 103, Albuquerque, New Mexico 87106, United States
- Advanced Materials Laboratory, Sandia National Laboratories , 1001 University Blvd. SE, Suite 100, Albuquerque, New Mexico 87106, United States
- Comprehensive Cancer Center, The University of New Mexico , MSC07 4025, 1 University of New Mexico, 1201 Camino de Salud NE, Albuquerque, New Mexico 87131-0001, United States
| |
Collapse
|
44
|
Sun B, Wang X, Liao YP, Ji Z, Chang CH, Pokhrel S, Ku J, Liu X, Wang M, Dunphy DR, Li R, Meng H, Mädler L, Brinker CJ, Nel AE, Xia T. Repetitive Dosing of Fumed Silica Leads to Profibrogenic Effects through Unique Structure-Activity Relationships and Biopersistence in the Lung. ACS Nano 2016; 10:8054-66. [PMID: 27483033 PMCID: PMC5214959 DOI: 10.1021/acsnano.6b04143] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Contrary to the notion that the use of fumed silica in consumer products can "generally (be) regarded as safe" (GRAS), the high surface reactivity of pyrogenic silica differs from other forms of synthetic amorphous silica (SAS), including the capacity to induce membrane damage and acute proinflammatory changes in the murine lung. In addition, the chain-like structure and reactive surface silanols also allow fumed silica to activate the NLRP3 inflammasome, leading to IL-1β production. This pathway is known to be associated with subchronic inflammation and profibrogenic effects in the lung by α-quartz and carbon nanotubes. However, different from the latter materials, bolus dose instillation of 21 mg/kg fumed silica did not induce sustained IL-1β production or subchronic pulmonary effects. In contrast, the NLRP3 inflammasome pathway was continuously activated by repetitive-dose administration of 3 × 7 mg/kg fumed silica, 1 week apart. We also found that while single-dose exposure failed to induce profibrotic effects in the lung, repetitive dosing can trigger increased collagen production, even at 3 × 3 mg/kg. The change between bolus and repetitive dosing was due to a change in lung clearance, with recurrent dosing leading to fumed silica biopersistence, sustained macrophage recruitment, and activation of the NLRP3 pathway. These subchronic proinflammatory effects disappeared when less surface-reactive titanium-doped fumed silica was used for recurrent administration. All considered, these data indicate that while fumed silica may be regarded as safe for some applications, we should reconsider the GRAS label during repetitive or chronic inhalation exposure conditions.
Collapse
Affiliation(s)
- Bingbing Sun
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Xiang Wang
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Yu-Pei Liao
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Zhaoxia Ji
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Chong Hyun Chang
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Suman Pokhrel
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, Germany
| | - Justine Ku
- Department of Ecology and Evolutionary Biology, University of California, Los Angeles, CA 90095, United States
| | - Xiangsheng Liu
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Meiying Wang
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Darren R. Dunphy
- Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Ruibin Li
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
- School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China
| | - Huan Meng
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Lutz Mädler
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, Germany
| | - C. Jeffrey Brinker
- Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Self-Assembled Materials Department, Sandia National Laboratories, PO Box 5800 MS1349, Albuquerque, New Mexico 87185, United States
| | - André E. Nel
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
- Address correspondence to or
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
- Address correspondence to or
| |
Collapse
|
45
|
Butler KS, Durfee PN, Theron C, Ashley CE, Carnes EC, Brinker CJ. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery. Small 2016; 12:2173-85. [PMID: 26780591 PMCID: PMC4964272 DOI: 10.1002/smll.201502119] [Citation(s) in RCA: 117] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Revised: 09/21/2015] [Indexed: 05/22/2023]
Abstract
Mesoporous silica nanoparticle-supported lipid bilayers, termed 'protocells,' represent a potentially transformative class of therapeutic and theranostic delivery vehicle. The field of targeted drug delivery poses considerable challenges that cannot be addressed with a single 'magic bullet'. Consequently, the protocell has been designed as a modular platform composed of interchangeable biocompatible components. The mesoporous silica core has variable size and shape to direct biodistribution and a controlled pore size and surface chemistry to accommodate diverse cargo. The encapsulating supported lipid bilayer can be modified with targeting and trafficking ligands as well as polyethylene glycol (PEG) to effect selective binding, endosomal escape of cargo, drug efflux prevention, and potent therapeutic delivery, while maintaining in vivo colloidal stability. This review describes the individual components of the platform, including the mesoporous silica nanoparticle core and supported lipid bilayer, their assembly (by multiple techniques) into a protocell, and the combined, often synergistic, performance of the protocell based on in vitro and in vivo studies, including the assessment of biocompatibility and toxicity. In closing, the many emerging variations of the protocell theme and the future directions for protocell research are commented on.
Collapse
Affiliation(s)
- Kimberly S. Butler
- Center for Micro-Engineered Materials, The University of New Mexico, Albuquerque, NM 87131 USA
| | - Paul N. Durfee
- Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131 USA
| | - Christophe Theron
- Center for Micro-Engineered Materials, The University of New Mexico, Albuquerque, NM 87131 USA
| | - Carlee E. Ashley
- Bioenergy and Defense Technology Department, Sandia National Laboratories, Livermore, CA 94551 USA
| | - Eric C. Carnes
- Nanobiology Department, Sandia National Laboratories, Livermore, California 94551
| | - C. Jeffrey Brinker
- Department of Chemical and Biological Engineering, The University of New Mexico, Albuquerque, NM 87131 USA. Center for Micro-Engineered Materials, The University of New Mexico, Albuquerque, NM 87131 USA. Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185
| |
Collapse
|
46
|
Savage TJ, Dunphy DR, Harbaugh S, Kelley-Loughnane N, Harper JC, Brinker CJ. Influence of Silica Matrix Composition and Functional Component Additives on the Bioactivity and Viability of Encapsulated Living Cells. ACS Biomater Sci Eng 2015; 1:1231-1238. [DOI: 10.1021/acsbiomaterials.5b00261] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Travis J. Savage
- Chemical & Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87106, United States
| | - Darren R. Dunphy
- Chemical & Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87106, United States
| | - Svetlana Harbaugh
- Air
Force Research Laboratory, Human Effectiveness Directorate, Wright-Patterson Air Force Base, Dayton, Ohio 45433, United States
| | - Nancy Kelley-Loughnane
- Air
Force Research Laboratory, Human Effectiveness Directorate, Wright-Patterson Air Force Base, Dayton, Ohio 45433, United States
| | | | - C. Jeffrey Brinker
- Chemical & Biological Engineering, University of New Mexico, Albuquerque, New Mexico 87106, United States
| |
Collapse
|
47
|
Sun B, Pokhrel S, Dunphy DR, Zhang H, Ji Z, Wang X, Wang M, Liao YP, Chang CH, Dong J, Li R, Mädler L, Brinker CJ, Nel AE, Xia T. Reduction of Acute Inflammatory Effects of Fumed Silica Nanoparticles in the Lung by Adjusting Silanol Display through Calcination and Metal Doping. ACS Nano 2015; 9:9357-9372. [PMID: 26200133 PMCID: PMC4687969 DOI: 10.1021/acsnano.5b03443] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The production of pyrogenic (fumed) silica is increasing worldwide at a 7% annual growth rate, including expanded use in food, pharmaceuticals, and other industrial products. Synthetic amorphous silica, including fumed silica, has been generally recognized as safe for use in food products by the Food and Drug Administration. However, emerging evidence from experimental studies now suggests that fumed silica could be hazardous due to its siloxane ring structure, high silanol density, and "string-of-pearl-like" aggregate structure, which could combine to cause membrane disruption, generation of reactive oxygen species, pro-inflammatory effects, and liver fibrosis. Based on this structure-activity analysis (SAA), we investigated whether calcination and rehydration of fumed silica changes its hazard potential in the lung due to an effect on silanol density display. This analysis demonstrated that the accompanying change in surface reactivity could indeed impact cytokine production in macrophages and acute inflammation in the lung, in a manner that is dependent on siloxane ring reconstruction. Confirmation of this SAA in vivo, prompted us to consider safer design of fumed silica properties by titanium and aluminum doping (0-7%), using flame spray pyrolysis. Detailed characterization revealed that increased Ti and Al doping could reduce surface silanol density and expression of three-membered siloxane rings, leading to dose-dependent reduction in hydroxyl radical generation, membrane perturbation, potassium efflux, NLRP3 inflammasome activation, and cytotoxicity in THP-1 cells. The reduction of NLRP3 inflammasome activation was also confirmed in bone-marrow-derived macrophages. Ti doping, and to a lesser extent Al doping, also ameliorated acute pulmonary inflammation, demonstrating the possibility of a safer design approach for fumed silica, should that be required for specific use circumstances.
Collapse
Affiliation(s)
- Bingbing Sun
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Suman Pokhrel
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, Germany
| | - Darren R. Dunphy
- Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
| | - Haiyuan Zhang
- Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, China
| | - Zhaoxia Ji
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Xiang Wang
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Meiying Wang
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Yu-Pei Liao
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Chong Hyun Chang
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
| | - Juyao Dong
- Department of Chemistry, University of California, Los Angeles, CA 90095, United States
| | - Ruibin Li
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
| | - Lutz Mädler
- Foundation Institute of Materials Science (IWT), Department of Production Engineering, University of Bremen, Germany
| | - C. Jeffrey Brinker
- Department of Chemical and Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico 87131, United States
- Self-Assembled Materials Department, Sandia National Laboratories, PO Box 5800 MS1349, Albuquerque, New Mexico 87185, United States
| | - André E. Nel
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
- Address correspondence to or
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, University of California, Los Angeles, CA 90095, United States
- California NanoSystems Institute, University of California, Los Angeles, CA 90095, United States
- Address correspondence to or
| |
Collapse
|
48
|
Lou YR, Kanninen L, Kaehr B, Townson JL, Niklander J, Harjumäki R, Jeffrey Brinker C, Yliperttula M. Silica bioreplication preserves three-dimensional spheroid structures of human pluripotent stem cells and HepG2 cells. Sci Rep 2015; 5:13635. [PMID: 26323570 PMCID: PMC4555166 DOI: 10.1038/srep13635] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2015] [Accepted: 07/30/2015] [Indexed: 11/19/2022] Open
Abstract
Three-dimensional (3D) cell cultures produce more in vivo-like multicellular structures such as spheroids that cannot be obtained in two-dimensional (2D) cell cultures. Thus, they are increasingly employed as models for cancer and drug research, as well as tissue engineering. It has proven challenging to stabilize spheroid architectures for detailed morphological examination. Here we overcome this issue using a silica bioreplication (SBR) process employed on spheroids formed from human pluripotent stem cells (hPSCs) and hepatocellular carcinoma HepG2 cells cultured in the nanofibrillar cellulose (NFC) hydrogel. The cells in the spheroids are more round and tightly interacting with each other than those in 2D cultures, and they develop microvilli-like structures on the cell membranes as seen in 2D cultures. Furthermore, SBR preserves extracellular matrix-like materials and cellular proteins. These findings provide the first evidence of intact hPSC spheroid architectures and similar fine structures to 2D-cultured cells, providing a pathway to enable our understanding of morphogenesis in 3D cultures.
Collapse
Affiliation(s)
- Yan-Ru Lou
- Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, the University of Helsinki, Helsinki 00014, Finland
| | - Liisa Kanninen
- Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, the University of Helsinki, Helsinki 00014, Finland
| | - Bryan Kaehr
- Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185, USA.,Department of Chemical and Biomolecular Engineering, the University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Jason L Townson
- Division of Molecular Medicine, Department of Internal Medicine, the University of New Mexico, Albuquerque, New Mexico 87131, USA.,Center for Micro-Engineered Materials, the University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Johanna Niklander
- Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, the University of Helsinki, Helsinki 00014, Finland
| | - Riina Harjumäki
- Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, the University of Helsinki, Helsinki 00014, Finland
| | - C Jeffrey Brinker
- Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185, USA.,Department of Chemical and Biomolecular Engineering, the University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Marjo Yliperttula
- Centre for Drug Research, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, the University of Helsinki, Helsinki 00014, Finland
| |
Collapse
|
49
|
Johnson PE, Muttil P, MacKenzie D, Carnes EC, Pelowitz J, Mara NA, Mook WM, Jett SD, Dunphy DR, Timmins GS, Brinker CJ. Spray-Dried Multiscale Nano-biocomposites Containing Living Cells. ACS Nano 2015; 9:6961-77. [PMID: 26083188 DOI: 10.1021/acsnano.5b01139] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Three-dimensional encapsulation of cells within nanostructured silica gels or matrices enables applications as diverse as biosensors, microbial fuel cells, artificial organs, and vaccines; it also allows the study of individual cell behaviors. Recent progress has improved the performance and flexibility of cellular encapsulation, yet there remains a need for robust scalable processes. Here, we report a spray-drying process enabling the large-scale production of functional nano-biocomposites (NBCs) containing living cells within ordered 3D lipid-silica nanostructures. The spray-drying process is demonstrated to work with multiple cell types and results in dry powders exhibiting a unique combination of properties including highly ordered 3D nanostructure, extended lipid fluidity, tunable macromorphologies and aerodynamic diameters, and unexpectedly high physical strength. Nanoindentation of the encasing nanostructure revealed a Young's modulus and hardness of 13 and 1.4 GPa, respectively. We hypothesized this high strength would prevent cell growth and force bacteria into viable but not culturable (VBNC) states. In concordance with the VBNC state, cellular ATP levels remained elevated even over eight months. However, their ability to undergo resuscitation and enter growth phase greatly decreased with time in the VBNC state. A quantitative method of determining resuscitation frequencies was developed and showed that, after 36 weeks in a NBC-induced VBNC, less than 1 in 10,000 cells underwent resuscitation. The NBC platform production of large quantities of VBNC cells is of interest for research in bacterial persistence and screening of drugs targeting such cells. NBCs may also enable long-term preservation of living cells for applications in cell-based sensing and the packaging and delivery of live-cell vaccines.
Collapse
Affiliation(s)
| | | | | | - Eric C Carnes
- #Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | - Jennifer Pelowitz
- #Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| | | | | | | | | | | | - C Jeffrey Brinker
- #Advanced Materials Laboratory, Sandia National Laboratories, Albuquerque, New Mexico 87185, United States
| |
Collapse
|
50
|
Harper JC, Carson BD, Bachand GD, Arndt WD, Finley MR, Brinker CJ, Edwards TL. Laser Machined Plastic Laminates: Towards Portable Diagnostic Devices for Use in Low Resource Environments. ELECTROANAL 2015. [DOI: 10.1002/elan.201500359] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|